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1. Systems biology, peptidomics and metabolomics
Over the past two centuries, medical science has been mostly based on reductionism, 
meaning the dividing of complex problems into smaller, simpler units. The human body 
was viewed as a collection of components, and the component most likely responsible for a 
certain condition was singled out as drug target. This approach has been successful in dealing 
with several widespread diseases, but it ignores the important role of interactions between 
system components. After the Human Genome Project was completed, it became clear that 
most phenotypic defects, such as cancer, asthma or atherosclerosis, cannot be explained 
by a single genetic mutation. Without a system-level understanding of the functioning of 
genes, the benefits of the information that the Human Genome Project generated cannot 
be fully exploited. In popular words, the forest cannot be explained by studying the trees 
individually [1]. The realisation that reductionism is not sufficient to achieve breakthroughs 
in health care is further strengthened by the fact that the number of drugs annually allowed 
on the market by the Food and Drug Administration has continued to decrease, while 
the costs that have to be made before a drug is allowed on the market have increased [2]. 
Medical systems biology offers a holistic approach, which not only takes interactions between 
genes into account, but also interactions between proteins and metabolites. Systems biology 
studies biology as an integrated system of genetic, protein, peptide, metabolite, cellular and 
pathway events that are in flux and interdependent. This offers an opportunity to overcome 
the limitations that the medical sciences and pharmaceutical industry currently face [3].
Peptidomics has been defined as the comprehensive qualitative and quantitative analysis 
of all peptides of a given biological system at a definite point in time. The concentration 
of peptides reflects detailed information about the physiological status of an organism [4]. 
The metabolome has been defined as the complete set of metabolites and/or low molecular 
weight intermediates, which is context dependent, varying according to the physiology, 
developmental or pathological state of the cell, tissue, organ or organism. Metabolomics is the 
analysis of the individual metabolites in an organism [5], i.e. the metabolome. Information 
of the concentration behaviour of peptides and metabolites in time is essential to be able 
to study a system. The importance of metabolomics has been demonstrated elegantly in 
yeast cultures. Yeast strains with so-called silent mutations cannot be distinguished based on 
their growth curves, but metabolomics analysis clearly showed different metabolic profiles 
that were caused by these mutations. Based on these results, ‘silent’ genes that influence 
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metabolic pathways could be identified [6]. 
2. Practical systems biology
Systems biology is the integration of  chemistry, mathematics, biology and medicine 
with biostatistics and bioinformatics [3]. To conduct systems biology experiments, 
comprehensive sets of biological data should be obtained. After measurement, the data are 
pretreated, annotated with the help of a database, visualised using multivariate statistical 
methods (Fig. 1.1) and biologically interpreted. This workflow may result in the discovery of 
a set of biomarkers that are indicative (either they play a direct role in the pathways, or they 
correlate to them) for the presence of a disease or drug-based intervention [7].
Figure 1.1 Example of a visualised biological system based on experimental data obtained from adipose 
tissue. It represents a correlation network based on transcript levels, protein concentrations and metabolite 
concentrations, determined with RNA-assays, LC-MS and GC-MS, respectively (kindly provided by Aram 
Adourian, BG Medicine Inc.).
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One of the main technological challenges with respect to practical systems biology is the 
development of sensitive tools for identifying and quantifying the concentrations, fluxes 
and interactions of various types of molecules, at high spatial and time resolution [8]. This 
challenge can be summarised into three requirements for analytical method development.
Requirement 1: The analytical method/technique should provide a wide concentration   
               range with a low detection limit
Low abundant metabolites are often highly relevant for the functioning of a system, 
and in consequence thereof, should be measured. The peptidome and metabolome extend 
over an estimated 7-9 magnitude of concentration (pmol/L - mol/L) [7, 9]. Next, methods 
with low detection limits allow for smaller sample size, which is especially beneficial when 
limited sample volume can be obtained, as for example is often the case in time-resolved 
studies [10]. 
The International Union for Pure and Applied Chemistry (IUPAC) defines the limit of 
detection (LOD) as the concentration, CL, or the quantity, qL, derived from the smallest 
measure, xL, that can be detected with reasonable certainty for a given analytical procedure. 
The value of xL is given by the Equation 1:
1)  
where       is the mean of the blank measures, sbi    is the  standard deviation  of the blank 
measures, and k is a numerical factor chosen according to the confidence level desired [11]. 
For the LOD, a value of 3 is mostly used for k, which means that the smallest peak that 
can be detected with certainty has a signal-to-noise ratio of 3. Attempts have been made 
to define a limit of quantitation (LOQ), which is regarded as the lower limit for precise 
quantitative measurements. A value of 10 is suggested for k, but this has not been widely 
adapted by the scientific community [12]. 
Requirement 2: The total analysis time should be short
A thorough systems biology study involves analysis of large sample series. To cope with 
this number of analyses, the total analysis time, including sample pretreatment and data 
processing, should be as short as possible. 
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Requirement 3: The analytical method should allow the analysis of a wide range of 
  chemical entities 
Peptides and, to an even larger extent, metabolites range greatly in size and polarity, which 
offer major challenges to the analytical techniques that are used to carry out metabolomic 
studies.
3. Current analytical techniques applied in quantitative peptide  
 and metabolite profiling
The major objective of quantitative peptidomics and metabolomics is to measure the 
concentration of as many endogenous compounds as possible in a biological sample [4, 
5, 13, 14]. Currently, peptide analysis is mainly carried out with liquid chromatography 
(LC) coupled to mass spectrometry (MS) and sometimes with capillary electrophoresis 
(CE) coupled to MS [15]. Often, metabolite analysis is carried out with nuclear magnetic 
resonance (NMR) spectrometry, gas chromatography coupled to MS (GC-MS), LC-MS, 
and sometimes with CE-MS [13]. However, no single analytical method is currently capable 
of detecting all peptides and/or metabolites in a biological sample [16]. Every sample 
pretreatment will result in the loss of some classes of compounds, the number of possible 
separated peaks is usually lower than the number of compounds present, and there are no 
universal detectors allowing for detection of all compounds in all concentrations. Therefore, 
combinations of analytical techniques, including sample pretreatment, should be explored 
to increase total coverage of the sample composition and to enhance selectivity.
3.1 Detection
As mentioned in the previous paragraph, two detection methods are generally used: 
NMR (mostly metabolites) and MS (peptides as well as metabolites) [14].
NMR is widely applied in metabolomics studies, because it requires minimal sample 
pretreatment and is an unbiased, non-destructive and robust technology that allows for the 
determination of absolute concentrations [13, 14, 17]. However, the sensitivity of NMR 
is low, and therefore NMR is not well suited for quantitative analysis. Moreover, several 
chemical moieties, such as sulphates, cannot be detected with NMR [13, 14]. 
MS is sensitive, selective and can be used to obtain structural information of compounds, 
especially when ultra-high resolution MS and fragmentation techniques are used (MSn, MS-
16
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MS) [16, 18]. For these reasons, MS can be considered as the detection method of choice in 
peptidomics and metabolomics research. 
MS analysis requires ions in the gas phase. Several ionisation techniques have been 
developed to achieve this, the most important being electrospray ionisation (ESI). A major 
drawback of all commonly used ionisation techniques is the fact that the response factor 
may be affected by the composition of the sample. The simultaneous ionisation of multiple 
compounds causes unpredictable response signals, and may even cause compounds to 
remain undetected. This process is called ion suppression (IS). Due to the occurrence of IS, 
the sensitivity of MS is affected and, moreover, compounds cannot be quantified reliably. 
Therefore, direct-infusion MS (DI-MS), in which a sample is infused into the MS without 
prior separation, has limited applicability [14]. The ideal solution to avoid ion suppression 
would be to let analytes reach the MS one by one. To this end, separation methods are 
performed prior to transfer to the MS detector. The two main separation methods that are 
being employed are gas chromatography (GC) [18] and liquid chromatography (LC) [16, 
19], while the role of capillary electrophoresis (CE) is expanding [13].
3.2  Separation techniques in peptidomics and metabolomics
3.2.1  Gas chromatography
Since peptides are non-volatile and thermostabile, while derivatisation procedures to 
overcome this are very cumbersome in the case of peptides, GC is not suitable for peptide 
analysis. However, GC-MS is a valuable technique in the metabolomics field. It is capable of 
identifying and quantifying hundreds of metabolites in one sample [20]. Initially, GC-MS 
has been used mostly to obtain metabolic profiles of microorganisms and plants, but currently 
an increasing amount of applications to mammalian samples are reported. The resolving 
power of GC has been further enhanced by the development of GC x GC techniques. A 
drawback of GC is the relatively long separation time and the laborious sample pretreatment 
it requires, often including a time-consuming two-step derivatisation procedure to enhance 
volatility and thermostability of polar and medium polar metabolites [14].
3.2.2  Liquid chromatography
As in GC, the separation mechanism of LC is based on selective distribution of analytes 
between the mobile and the stationary phase. LC-MS is an attractive technique for 
producing metabolic and peptidomic fingerprints, since it is robust, sensitive and selective. 
17
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Moreover, normally no chemical derivatisation is required. LC has already been shown to be 
applicable to a wide range of peptides [15] as well as metabolites [14]. Recent developments 
of LC in peptidomics focus on improved separation, for example by the development of 
multidimensional separation platforms (i.e. LC x LC-MS), and improved LOD (nanoLC). 
Innovations in LC-based metabolomics developments aim at improving LOD (capillary LC, 
or μLC), efficiency (ultra-performance LC, UPLC) and selectivity (new column materials, 
such as materials that allow for hydrophilic interaction chromatography (HILIC)) [14, 16].
3.2.3  Capillary electrophoresis
CE is based on a separation mechanism that is completely different from the separation 
mechanism of chromatography. It is based on differences in electrophoretic mobility of 
charged compounds in an electric field. In principle, compounds are separated based on 
their mass-to-charge ratio. All peptides and many important metabolite classes, such as for 
example fatty acids, keto acids, acyl phosphates, phospholipids, acylcarnitines, amino acids, 
coenzyme A derivatives and nucleotides [21] are charged compounds or can be charged 
by choosing a suitable pH, and are therefore susceptible to CE. Many examples of the 
application of CE-MS to peptidomics and metabolomics can be found in literature [22-25]. 
While LC requires expensive columns and large amounts of solvents, CE requires only a 
cheap fused silica capillary and a minimal small amount of solvent. The separation efficiency 
of CE is unmatched. On top of this, CE can handle sample volumes as small as a few nL. 
An aspect that has delayed the growing interest in CE-MS, is the lack of robustness of the 
hyphenation of CE to MS, but significant progress is being made in this area [26]. Several 
capillary electrophoretic separation techniques have been developed; the most important 
being capillary zone electrophoresis (CZE), capillary gel electrophoresis (CGE) and 
micellar electrokinetic chromatography (MEKC). Moreover, on-line analyte enrichment is 
possible with various stacking methods, capillary isoelectric focusing (cIEF) and capillary 
isotachophoresis (cITP).
As electromigration-based techniques applied to peptides and metabolites are the main 
topic of this thesis, section 4 is devoted to introducing the theory of electrophoresis and its 
most common methods and applications. 
3.3  Sample pretreatment
3.3.1 Conventional sample pretreatment techniques
18
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In peptide analysis, sample pretreatment often involves ultrafiltration to remove proteins 
and SPE to remove salts [27]. For untargeted metabolic profiling, sample pretreatment 
should be as minimal as possible in order to avoid the exclusion of metabolites classes 
[13]. Often, sample pretreatment for untargeted metabolomics consists only of diluting 
the sample. However, the high salt and, in plasma and serum, protein contents present 
in biological matrices can interfere with both separation and detection. Therefore, some 
sample pretreatment is often carried out prior to analysis, to remove both proteins and salts. 
To remove proteins, protein precipitation with organic solvents is commonly applied [7, 
29], while for the desalting of samples, reversed phase solid phase extraction (RP-SPE) is 
mostly used [7]. When a specific set of metabolites is studied, a more selective approach can 
be used, for example by using alternative SPE materials such as ion exchange materials [28].
3.3.2 Electromigration-based sample pretreatment
In chromatography-based sample pretreatment, the injection of more sample volume 
(bulk) into analytical systems can be attractive to achieve lower LOD values. However, 
this approach is limited, since it usually also increases the amount of contaminants and 
bulk components that may disturb sample pretreatment, separation and detection. 
Instead of increasing the injected sample volume and along with it, the amount of injected 
contaminants, only the injected amount of analytes should be increased. Under well-chosen 
experimental conditions, electromigration is capable of offering this selectivity, leaving 
neutral components and, depending on the polarity of the electric field, either cations or 
anions behind. 
Another strong argument for using electromigration-based sample pretreatment is the 
fact that chromatography and electrophoresis can complement each other, since they are 
based on different mechanisms, as mentioned above. The results shown in for example [30] 
and [31] underline the complementary nature of electromigration-based techniques to 
chromatography-based techniques. In [30], human urine of male and female subjects was 
analysed with CE-MS and LC-MS. The results were analysed with principal component 
analysis (PCA) plotting and with both separation techniques, male and female subjects 
could be distinguished. When the classifying features were studied and compared, it was 
revealed that different features were responsible for the gender classification. In [31], it was 
shown that when electrodialysis was used as sample pretreatment, other peptides in synovial 
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The potential of electromigration-based sample pretreatment of large volumes is not 
yet fully exploited by the analytical community, while in the field of CE-based techniques 
it is already common practice to use electrophoretic mechanisms to selectively and rapidly 
concentrate analytes [32-34]. Electromigration-based sample pretreatment is especially 
suitable for trace analysis, because it offers removal of bulk components and selective 
concentration of trace compounds in one single step [35]. 
For targeted analysis, preparative isotachophoresis and isoelectric focusing have been 
used [36]. Zone electrophoresis sample treatment (ZEST) was presented in the late 80s and 
early 90s. A special valve was developed and coupled on-line to LC. With this valve, several 
pharmaceuticals could be isolated within 15 min from rather large biological samples (20 
μL), based on their electrophoretic migration velocities. [37-39]. Despite the promising 
results that were presented, no recent literature can be found on ZEST. 
More recent examples of electromigration-based sample pretreatment techniques 
mostly employ field-amplified transport across phase boundaries and membranes, the 
most important being electro-membrane extraction (EME), electrodialysis (ED) and 
electroextraction (EE) [35]. 
In ED, charged analytes migrate from one solution into another through a semi-
permeable membrane under the influence of an electric field [31, 40, 41]. To our knowledge, 
ED is the only electromigration-based method that has been used as sample pretreatment 
procedure for metabolite or peptide profiling. In [31], the feasibility of ED for fast and 
selective sample pretreatment method for the profiling of low-abundant peptides in synovial 
fluid was demonstrated. After ED, the extracted peptides were analysed with nanoLC-
MS and several new peptides were found compared to conventional sample pretreatment 
(ultrafiltration combined with RP-SPE).
In electro-membrane extraction (EME), an organic solvent is immobilised in the pores 
of a probe consisting of polymeric material and serves, upon application of an electric field, 
to enhance the extraction rate when the probe is immersed in a donor solution. As a result, 
extraction is faster and the enrichment is typically one order of magnitude. Extraction takes 
place from an aqueous sample, via the immobilised organic solvent, into another aqueous 
acceptor solvent. This promising method has been applied successfully to the analysis of 
several pharmaceuticals in plasma and urine [35, 39, 42], and also peptides spiked to plasma 
[43], but not to metabolomics. In EME of peptides, however, the structure of the peptide 
(i.e. polarity and charge) influences the extraction efficiency strongly (some peptides were, 
due to their structure, not extracted at all) [44], making the method suitable for selective 
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(targeted) analysis, but less for peptidomics. The extraction of peptides spiked to plasma 
showed moderate recoveries of 25% to 43% and endogenous levels could not be detected 
[43]. However, EME has been studied well, its feasibility has been demonstrated and it 
might become a useful tool for analyte isolation in the future. 
Electroextraction (EE) is electromigration-assisted liquid-liquid extraction, where 
analytes migrate from the donor solvent into the immiscible acceptor solvent when an 
electric field is applied [45]. The mechanism of EE and its application to peptides and 
metabolites in biological samples is discussed and presented in detail in chapter 3, 4, and 5 
of this thesis.
4.  Introduction in electrophoresis
Electrophoresis is the movement of charged species due to attraction or repulsion in 
an electric field. It was introduced as a separation technique by Arne Tiselius when he 
demonstrated ‘the moving-boundary method of studying the electrophoresis of proteins’ 
[46]. He performed electrophoretic experiments on protein mixtures that were in a tube 
between buffer solutions and showed that the sample components migrated in a direction 
and that the migration rate was determined by the mobility of the component. Later, he was 
awarded the Nobel Prize for this work.
The electrophoretic velocity of an ion is described as [47, 48]:
2)  
where vep is ion velocity, μep the electrophoretic mobility and E the electric field strength. The 
electric field strength is described as [47, 48]:
3)  
where V is the applied voltage and Ltot the length over which V is applied.
The electrophoretic mobility is the balance between the attracting electric force and the 
opposing frictional force.
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The electric force is described as [47, 48]:
4)  
where z is the number of elemental charges on the ion and e the elemental charge. The 
frictional force for a spherical ion is described by Stokes’ Law [47, 48]:
5)  
where η is the dynamic viscosity, r the Stokes radius of the ion and vep the ion velocity. At the 
start of an electrophoresis experiment, the ions accelerate to reach a constant speed within 
a short time. At constant speed, the electric force and frictional force will be in equal and 
opposite [47, 48]:
6)  
When Equation 2 is substituted into Equation 7, μep can be defined as [47]:
7)  
In practice, this means that smaller ions with more elementary charges migrate faster.
4.1 Capillary electrophoresis
When electrophoretic experiments are carried out in free solution, as was the case in 
Tiselius’ experiments, thermal diffusion and convection have a detrimental effect on the 
separation efficiency. To deal with this, electrophoresis in anti-convective media such as 
agarose and polyacrylamide gels was developed. Currently, gel electrophoresis is common 
practice in biochemical laboratories and it is the most used form of electrophoresis, despite 
the low separation efficiency, long analysis time and laborious procedures that are difficult to 
automate. Furthermore, gel electrophoresis is only suitable for large biomolecules (proteins, 
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DNA).
By performing electrophoresis in a capillary, high performance fast separations can be 
carried out, thanks to the very high electric field strengths that can be applied. A common 
experimental condition is the application of 30 kV on a capillary with a length of 50 cm, 
resulting in an electric field strength of 60 kV/m. Because of the very small inner diameter 
of a capillary (50-100 μm), only low currents (10-250 μA) are generated. Therefore, limited 
heat generation takes place, even at very high voltages. The little heat that is generated 
is easily dissipated to the environment because of the high surface-to-volume ratio of a 
capillary. As a consequence, the influence of thermal diffusion and convection is limited, 
and high performance electrophoresis can be carried out in free solution. 
Capillary electrophoresis was pioneered in the 1960s by Hjertén [49], who performed 
separations in 1 mm quartz tubes that were coated with methyl cellulose and immersed in 
a water bath to dissipate Joule heating. The quartz allowed for UV detection. In the 1970s, 
Mikkers et al performed CE in a narrow-bore PTFE (Teflon) tube (0.2 mm ID, 0.35 mm 
OD), which was the first high performance CE experiment [50]. In the 1980s, CE in open, 
tubular glass capillaries (75 μm ID, 550 μm OD) developed by Jorgenson and Lukacs [51], 
resulting in the commercially employed technique that CE is nowadays. From then on, CE 
received increasing attention, resulting in the development of several CE-based separation 
and on-line concentration methods, and commercial CE equipment. A basic CE set-up 
consists of a capillary filled with background electrolyte, a high voltage supply, buffer vials 
and two electrodes [47]. Usually, the capillary is made of fused silica. In aqueous solutions, 
the silanol groups of the capillary wall can (depending on the pH) become deprotonated, 
which results in a negatively charged wall. The negatively charged wall attracts cations from 
the solution, which form a layer. As soon as the separation voltage is applied, the layer of 
cations starts migrating, dragging the rest of the bulk liquid with it. The resulting flow is 
called electro-osmotic flow (EOF). The flow profile of EOF is typically flat, which is the 
main reason that, in spite of the fact that a bulk flow exists, very high separation efficiencies 
can be achieved with CE in comparison with LC, where hydrodynamic flow leads to a 
parabolic flow profile [47].
Detection in CE initially usually took place using spectrophotometry, via a detection 
window in the capillary. Nowadays, robust CE-MS hyphenation has been achieved [26]. 
The most important CE separation methods are capillary zone electrophoresis (CZE), 
capillary electrochromatography (CEC), capillary gel electrophoresis (CGE) and micellar 
electrokinetic chromatography (MEKC). Moreover, CE can be used for on-line analyte 
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concentration. On-line concentration methods are based on smart buffer choice, which 
induces field-amplified or chemically induced sample stacking. These processes can be 
employed to concentrate analytes on-line and in conjunction with a consecutive separation. 
Two CE methods can be used to concentrate and separate analytes simultaneously, namely 
capillary isoelectric focusing (cIEF) and capillary isotachophoresis (cITP).
4.2  CE separation techniques
4.2.1 Capillary zone electrophoresis
In CZE, the most common CE form, analytes are separated based on their different 
electrophoretic mobilities after they are injected into a capillary that is filled with background 
electrolyte and a separation voltage is applied. Thanks to the presence of EOF, both cations 
and anions can be analysed in one run. Neutral compounds cannot be separated with CZE 
[47].
Non-aqueous capillary electrophoresis (NACE) is increasingly gaining interest. In NACE, 
the background electrolyte consists of an organic solvent. As a rule, non-aqueous solvents 
are less conductive than aqueous solvents. Therefore, low currents exist in NACE and hardly 
any Joule heating is produced. As a consequence, higher electric field strengths as well as 
wider bore capillaries can be used. Due to higher electric field strengths, separation efficiency 
can be enhanced, while wider bore capillaries enable the injection of more sample volume 
and so offer lower LOD values. Moreover, separation selectivity can be easily manipulated 
with various optional organic solvents. Since organic solvents are mostly volatile and have a 
low surface tension, which is beneficial for electrospray, NACE-MS will probably be applied 
more often in the near future [52]. Currently, relatively few bio-analytical applications of 
NACE have been reported [53, 54], but given the high potential that has been shown so far, 
this may well change in the coming decade.
4.2.2 Capillary electrochromatography
CEC is a hybrid separation method of CZE and chromatography. Separation takes place 
in a capillary that is packed or coated with a stationary phase. The separation principle of 
CEC is based on differences in electrophoretic mobility and differences in affinity for the 
stationary phase. As a consequence, CEC is capable of separating ionic as well as neutral 
compounds. The neutral components are only separated due to difference in their affinity 
for the stationary phase. When the analytes are transported towards the detector by EOF, 
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very sharp peaks can be obtained [47].
4.2.3 Capillary gel electrophoresis
CGE is almost uniquely applied to DNA analysis. DNA molecules of different size 
have similar mass-to-charge ratios, since each extra building block also introduces an extra 
charge. Therefore, their electrophoretic mobilities are similar, and conventional CZE does 
not suffice for good separation. By carrying out the separation in a capillary filled with 
cross-linked polyacrylamide, analytes can be separated based on their size. The separation 
speed of CGE is around five times faster than slab gel electrophoresis and can be carried out 
in automated multiplex mode. The invention of CGE and the development of multiplexed 
CGE with stabile gel matrices and multiple-capillary detection have significantly accelerated 
the completion of the sequencing of the Human Genome Project [55], which is still one of 
the most remarkable successes of CE. 
4.2.4 Micellar electrokinetic chromatography
MEKC is, like CEC, capable of separating neutral analytes. This is achieved by adding 
an ionic surfactant to the background electrolyte in a concentration that is above its critical 
micelle concentration. The micelles serve as a pseudo-stationary phase and analytes will be 
distributed between the micelles and the aqueous buffer. Often, sodium dodecyl sulphate 
(SDS) micelles are employed. When an electric field is applied, an injected sample will 
migrate towards the anode due to EOF, while the anionic SDS micelles migrate towards 
the cathode. Separation of the neutral analytes then takes place according to differences in 
selective distribution between the buffer and the micelles [56]. With MEKC, highly efficient 
separations can be achieved, but its main drawback is the cumbersome coupling to MS, due 
to the presence of high levels of surfactants. With the partial filling approach, MEKC has 
been successfully coupled to MS [55]. There is also evidence that MEKC can be coupled 
directly to MS with atmospheric pressure chemical ionisation (APCI) [57, 58].
4.3 On-line sample concentration 
Electrophoresis is a process of ion fluxes, and by carefully selecting the experimental 
conditions, an analyte flux can be generated and on-line preconcentration can be performed, 
leading to an enhanced LOD of the method. CE injections that allow for good consecutive 
separation typically are around 1% of the capillary volume, which is in the low nL range. 
For example, 1% of the volume of a conventionally dimensioned capillary (75 μm ID x 1 
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m length) means only 20 nL sample is used. Due to the low volume loadability of CE, the 
determination of (very) low abundant compounds is often problematic. Moreover, relevant 
biological compounds often occur in very low concentrations. In LC-based analysis, a simple 
solution for this is to inject more sample volume, but this often compromises separation or 
leads to fouling of the system. To achieve LOD values, an analyte flux instead of bulk flow 
should be generated. The nature of electromigration and the capillary format offers excellent 
possibilities for on-line sample preconcentration by carefully selecting suitable buffers or 
electrolytes. Below, the most commonly used on-line sample concentration techniques 
are discussed briefly, divided in stacking techniques (field-amplified stacking (FASS) and 
chemically-induced stacking) and techniques that concentrate and separate simultaneously 
(cIEF and cITP).
In chapter 2 of this thesis, the potential of cITP-MS is explored and the 
development of a highly effective special type of FASS is studied and applied for the 
first time in bioanalysis, namely electroextraction, is shown in chapter 3, 4 and 5. 
4.3.1 Field-amplified sample stacking
FASS  relies on a conductivity difference between the sample and the running buffer. The 
work on electroextraction, which is described in this thesis in chapter 3, 4 and 5, is also a 
form of FASS. 
When the injected sample has a lower conductivity than the background electrolyte, a 
higher electric field strength exists over the sample plug than over the rest of the capillary, 
according to Ohm’s law. Equation 2 states that the electrophoretic velocity (v) is proportional 
to the electric field strength (E). Therefore, the sample molecules will migrate faster in the 
sample zone than in the buffer zone. As soon as the sample molecules migrate out of the 
sample zone, into the buffer zone, they slow down and are stacked [32].
4.3.2 Chemically induced sample stacking
Analytes can be stacked on the boundary between sample and background by chemically 
changing their electrophoretic velocities. The most common ways of achieving this 
are dynamic pH junction and sweeping [34]. In a dynamic pH junction, the pH of the 
background electrolyte is chosen such that the analyte becomes neutral when it enters it. 
As a consequence, the electrophoretic velocity of the analyte drops to zero and the analytes 
are concentrated [34]. In sweeping, a pseudo-stationary phase as used in MEKC is injected 
after the sample plug. When the pseudo-stationary phase migrates through the sample zone 
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it picks up and concentrates the analytes, i.e. it ‘sweeps’ the analytes into a very sharp zone. 
The concentration gain is dependent on the affinity of the analyte to the pseudo-stationary 
phase [34].
4.4  Simultaneous concentration and separation
Two CE techniques are capable of separating and concentrating analytes in one step, 
namely cIEF and cITP. In both methods, analytes are concentrated in so-called self-
sharpening zones that are adjacent to each other.
4.4.1 cIEF
cIEF is only suitable for ampholytic compounds and specifically applied in peptide and 
protein analysis. In a cIEF experiment, a pH gradient is created in the capillary with the help 
of carrier ampholytes. An analyte electromigrates through the pH gradient until it reaches 
the zone where the pH is equal to its pI value; in this zone it becomes electrically neutral 
and ceases to migrate further. Due to this mechanism, analytes are separated according to 
their pI value and simultaneously concentrated in their pH zones.  The analyte zones are 
self-correcting; when an analyte molecule diffuses from its zone, it enters another pH, gets 
charged and migrates back [59].
4.4.2 cITP
In cITP, the sample is injected between two different electrolytes: the leading 
electrolyte (LE) and a terminating electrolyte (TE). The choice of electrolytes is based on 
the electrophoretic mobility of the analytes: the LE contains an ion species with a higher 
electrophoretic mobility and the TE contains an ion species with a lower electrophoretic 
mobility than the analytes. When an electric field is applied in this system, a steady-state will 
be formed which results in the formation of ‘a train’ of analyte zones that all migrate with 
equal speed. The analytes are arranged according to their electrophoretic mobilities [60]. 
According to Kohlrausch’s regulation function (Equation 8), the concentration of ion a (the 
analyte) is dependent on the concentration of the preceding ion l (the leading ion) [47]. 
8)   
In this equation, Ca and Cl are the molar analyte and LE concentrations, respectively, 
and μa, μr and μl are the electrophoretic mobilities, respectively, of the analyte a, counter 
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ion r and the leading ion l. The consequence of this process is that analytes that occur in 
concentrations below the LE concentration will be concentrated and compounds that occur 
in concentrations above the LE concentration will be diluted. For this reason, cITP has a 
high dynamic range and is very suitable for analysis of trace compounds in complex samples. 
Each analyte zone has its own electric field strength value, which results in self-sharpening 
zones. When an analyte diffuses out of its own specific zone, it will be delayed or sped up 
back to its own zone due to the lower or higher electric field strength it meets in the adjacent 
zone. In an ITP experiment, either cations or anions can be separated in one experiment 
and the analyte zones are being formed directly adjacent to each other. In other words, 
they are not physically separated and an isotachopherogram does not contain peaks, but a 
series of block signals. At the borders of the analyte zones, a mixed zone exists that contains 
both analytes. In case of trace compounds, analyte zones become so narrow that during 
detection, it is impossible to detect them separately; they are mixed [61]. To separate the 
adjacent zones, cITP is often combined with CZE. In this combination, cITP is transient. 
In transient ITP (tITP), the capillary is filled with a LE zone, a sample zone, a short TE 
zone and again a LE zone, respectively. In the first instant, tITP is taking place, but within a 
short time, the TE zone is overtaken by the LE that was injected behind it. Then, the cITP 
system has become a CZE system and the analytes are separated [62].  A disadvantage of this 
process is that the zones lose their self-sharpening ability. Especially very narrow ITP zones 
will suffer from band-broadening, which partly cancels out the concentrating ITP effect and 
results in less favourable LOD values.
An alternative approach is the use of spacer molecules, which will be focused between the 
analytes [63]. In this way, analyte zones can be separated physically without losing the power 
of the ITP process. In chapter 2 of this thesis, the feasibility of this approach for plasma 
peptides is explored in order to couple ITP of peptides directly to MS detection. 
5. Scope and outline of the thesis
The paradigm shift from reductionism towards systems biology demands innovations 
from analytical chemistry. A good systems biology approach demands comprehensive 
knowledge of the identity and concentration of all metabolites and peptides, including 
low-abundant ones, in a multitude of (small) samples. The research fields of peptidomics 
and metabolomics require from analytical techniques improvements in LOD, speed and 
suitability to measure a wide range of analytes. 
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The goal of this thesis is to demonstrate that electrophoretic on-line concentration 
procedures meet these three requirements. Electromigration is capable of enhancing 
selective analyte migration. Selective analyte migration can be used to increase the amount of 
analyte that is injected into an analytical system, while it leaves the sample volume with the 
contaminants behind. In consequence, the injection of contaminants and bulk components 
that may disturb sample pretreatment, separation and detection can be avoided and LOD 
values can be lowered without the problems associated with direct injection of larger sample 
volumes. 
The work that is presented in this thesis is focused on fast electrophoresis-based LOD 
improvement of the analysis of peptides and/or metabolites in plasma and urine. 
In Chapter 2, the use of carrier ampholytes as spacer molecules to couple cITP of 
peptides directly to MS is explored. In this way, the isotachophoretic peptide zones can be 
separated from each other without losing ITP conditions, in this way enabling cITP-MS 
analysis with low LOD values of pure, highly concentrated trace peptides. 
The remainder of the thesis is devoted to the demonstration of electroextraction (EE) 
as on-line electrophoretic concentration technique for sensitive, fast and comprehensive 
peptide and metabolite profiling. In Chapter 3, to demonstrate the ability of EE to quickly 
extract a wide range of peptides from complex samples and concentrate them, a capillary 
EE (cEE) method is developed, its potential for coupling to LC-MS is demonstrated, and 
the resulting cEE-LC-MS system was applied to protein digests and endogenous peptides 
in urine.  To further increase analyte enrichment factors and speed, an improved new large 
volume cEE set-up that is capable of extracting larger volumes within a shorter time span 
is shown in Chapter 4. Furthermore, its on-line coupling to LC-MS and its applicability 
to plasma peptide analysis is studied. In Chapter 5, to demonstrate the comprehensiveness 
and versatility of EE, the capacity of large volume cEE to extract metabolites from untreated 




General introduction and scope
6. References
1 Ahn, C.A., Tewari, M., Poon, C-H., Phillips, R.S. PLoS Med, 2006, 3 (6), 709-713
2 Van der Greef, J., McBurney, R.N., Nat Rev Drug Discov, 2005, 4, 961-967
3 Van der Greef, J., Stroobant, P., Van der Heijden, R., Curr Opin Chem Biol, 2004, 8, 559-565
4 Schulz-Knappe, P., Schrader, M., Zucht, H-D., Comb Chem High Throughput Screen, 2005, 
8, 697-704
5 Griffin, J.L., Philos Trans R Soc Lond B Biol Sci, 2004 359, 1446, 857-71
6 Raamsdonk, L.M., Teusink, B., Broadhurst, D., Zhang, N., Hayes, A., Walsh, M.C., Berden, 
J.A., Brindle, K.M., Kell, D.B., Rowland, J.J., Westerhoff, H.V., Van Dam, K., Oliver, S.G., 
Nat Biotechnol, 2001, 19, 45-50
7 Dunn, W.B., Ellis, D.I., Trends Analyt Chem, 2005, 24, 4, 285-294
8 Aderem, A., Cell, 2005, 121, 511-513
9 Anderson, N.L., Anderson, N.G., Mol Cell Proteomics, 2002, 1, 845-867
10 Van der Greef, J., Martin, S., Adourian, A., Plasterer, T., Verheij, E.R., McBurney, R.N., J 
Proteome Res, 2007, 6, 1540-1559
11 McNaught, A.D., Wilkinson, A., Nic, M., Jirat, J., Kosata, B., Jenkins, A., IUPAC. Compendium 
of Chemical Terminology, 2006, 2nd edition (the “Gold Book”) Blackwell Scientific Publications, 
Oxford. XML on-line corrected version: http://goldbook.iupac.org (website consulted at 25 April 2012)
12 Miller, J.N., Miller, J.C., Statistics and chemometrics for analytical chemistry, 2000, 4th edition, 
Prentice Hall, 121-122
13 Ramautar, R., Somsen, G.W., De Jong, G.J., Electrophoresis, 2009, 30, 276-291
14 Xiayan, L., Legido-Quigley, C., Electrophoresis, 2008, 29, 3724-3736
15 Boonen,, K., Landuyt, B., Baggerman, G., Husson, S.J., Huybrechts, J., Schoofs, L., J Sep Sci, 
2008, 31, 427-445
16 Allwood, J.W., Goodacre, R., Phytochem Anal 2010, 21, 33-47
17 Beckonert, O., Keun, H.C., Ebbels, T.M.D., Bundy, J., Holmes, E., Lindon, J.C., Nicholson, 
J.K., Nat Protoc, 2007, 2, 11, 2692-2703
18 Zhang, X., Wei, D., Yap, Y., Li, L., Guo, S., Chen, F., Mass Spectrom Rev, 2007, 26, 403-431
19 Wilson, I.D., Plumb, R., Granger, J., Major, H., Williams, R., Lenz, E.M., J Chromatogr B, 
2005, 817, 67-76
20 Lisec, J., Schauer, N, Kopka, J., Willmitzer, L., Fernie, A.R., Nat Protoc, 2006, 1, 1, 387-396
21 Wishhart et al, Nucleic Acids Res, 2009, 37, D603-D610
22 Soga, T., Ohashi, Y., Ueno, Y., Naraoka, H., Tomita, M., Nishioka, T., J Proteome Res, 2003, 2, 
30
1
General introduction and scope
488-494
23 Hirayama, A., Kami, K., Sugimoto, M., Sugawara, M., Toki, N., Onozuka, H., Kinoshita, T., 
Saito, N., Ochiai, A., Tomita, M., Esumi, H., Soga, T., Cancer Res 2009, 69, 11, 4918-4925
24 Sugimoto, M., Wong, D.T., Hirayama, A., Soga, T., Tomita, M., Metabolomics, 2010, 6, 78-95
25 Schiffer, E., Mischak, H., Novak, J., Proteomics, 2006, 6, 5615-5627
26 Hommerson, P., Khan, A.M., De Jong, G.J., Somsen, G.W., Mass Spectrom Rev, 2011, 30, 6, 
1096-1120
27 Aristoteli, L.P., Molloy, M.P., Baker, M.S., J. Proteome Res, 2007, 6, 571-581
28 Griffiths, W.J., Sjövall, J., Biochem Biophys Res Commun, 2010, 396, 80-84
29 Villas-Bôas, S.G., Højer-Pedersen, J., Åkesson, M., Smedsgaard, J., Nielsen, J., Yeast, 2005, 22, 
1155-1169
30 Ramautar, R., Nevedomskaya, E., Mayboroda, O.A., Deelder, A.M., Wilson, I.D., Gika, H.G., 
Theodoridis, G.A., Somsen, G.W., De Jong, G.J., Mol Biosyst, 2011, 7, 194-199
31 Kamphorst, J.J., Tjaden, U.R., Van der Heijden, R., De Groot, J., Van der Greef, J., Hankemeier, 
T., Electrophoresis, 2009, 30, 2284-2292
32 Chien, R-L., Burgi, D.S., J Chromatogr, 1991, 559, 141-152
33 Britz-Kibbin, P., Terabe, S., J Chromatogr A, 2003, 1000, 917-934
34 Breadmore, B.C., Thabano, J.R.E., Dawod, M., Kazarian, A.A., Quirino, J.P., Guijt, R.M., 
Electrophoresis, 2009, 30, 230-248
35 Kubáň, P., Šlampová, A., Boček, P., Electrophoresis, 2010, 31, 768-785
36 Bier, M., Electrophoresis, 1998, 19, 1057-1063
37 Kok, W. Th., Hupe, K.P., Frei, R.W., J Chromatogr A, 1988, 436, 421-427
38 Debets, A.J.J., Hupe, K.-P., Brinkman, U.A.Th., Kok, W.Th., Chromatographia, 1990, 29, 5/6, 
217-222
39 Debets, A.J.J., Schoutsen, T.P., Kok, W.Th.,  Hupe, K.-P., Brinkman, U.A.Th., Chromatographia, 
1992, 34, 11/12, 581-588
40 Brewster, J.D., Piotrowski, E.G., J Chromatogr, 1991, 585, 213-217
41 Buscher, B.A.P., Tjaden, U.R., Van der Greef, J., J Chromatogr A, 1997, 788, 165-172
42 Pedersen-Bjergaard, S., Rasmussen, K.E., J Chromatogr A, 2006, 1109, 183-190
43 Balchen, M., Halvorsen, T.G., Reubsaet, L., Pedersen-Bjergaard, S., J Chromatogr A, 2009, 1216, 
6900-6905
44 Balchen, M., Reubsaet, L., Pedersen-Bjergaard, S., J Chromatogr A, 2008, 1194, 143-149
45 Stichlmair, J., Schmidt, J., Proplesch, R., Chem Eng Sci, 1992, 47, 12, 3015-3022
46 Tiselius, A., Trans. Faraday Soc, 1937, 33, 524-531
31
1
General introduction and scope
47 Mazereeuw, M., Tjaden, U.R., Capillaire Elektroforese, Chromatografie in de Praktijk, Ten Hagen 
Stam, december 1996, 1-88
48 Riekkola, M.-L., Jönsson, J. Å, Smith, R.M., Pure Appl Chem, 2004, 76 (2), 443-451
49 Hjertén, S., Chromatogr Rev, 1967, 9, 122-219
50 Mikkers, F.E.P., Everaerts, F.M., Verheggen, Th.P.E.M., J Chromatogr A, 1979, 169, 11-20
51 Jorgenson, J.W., Lukacs, K.D., Anal Chem, 1981, 53, 1298-1302
52 Riekkola, M.-L., Jussila, M, Porras, S.P., Valkó, I.E., J Chromatogr A, 2000, 892, 155-170
53 Lai, E.P.C., Feng, S.Y., J Chromatogr B, 2006, 843, 94-99
54 Sasajima, Y., Lim, L.W., Takeuchi, T., Suenami, K., Sato, K., Takekoshi, Y., J Chromatogr A, 
2010, 1217, 7598-7604
55 Karger, B.L., Guttman, A., Electrophoresis, 2009, 30, s196-s202
56 Terabe, S., Chem Rec, 2008, 8, 291-301
57 Takada, Y., Sakairi, M., Koizumi, H., Anal Chem, 1995, 67, 1474-1476
58 Yang, L., Lee, C.S., J Chromatogr A, 1997, 780, 207-218
59 Shimura, K., Electrophoresis, 2009, 30, 11-28
60 Petr, J., Maier, V., Horáková, J., Ševcík, J., Stránský, Z., J Sep Sci, 2006, 29, 2705-2715
61 Peterson, Z.D., Bowerbank, C.R., Collins, D.C., Graves, S.W., Lee, M.L., J Chromatogr A, 2003, 
992, 169-179
62 Timerbaev, A.R., Hirokawa, T., Electrophoresis, 2006, 27, 323-340
63 Chartogne, A., Reeuwijk, B., Hofte, B., Van der Heijden, R., Tjaden, U.R., Van der Greef, J., J 
Chromatogr A, 2002, 959, 289-298

Chapter 2 
Potential of capillary 
isotachophoresis coupled to 
mass spectrometry of peptides 
using spacer molecules
Based on 
Lindenburg, P.W., Tjaden, U.R., Van der Greef, J., Hankemeier, T. 
Potential of capillary isotachophoresis mass spectrometry of peptides using spacer molecules.





Capillary isotachophoresis (cITP) is an electrophoretic separation technique that is able to 
concentrate analytes during separation, in consequence improving the sample concentration 
detection limits. In health sciences, the importance of peptides is widely recognised, since 
changes in body fluid peptide profiles often reflect disturbed homeostasis or disease. The 
analysis of peptides is complicated, since peptides typically occur in very low concentrations. 
In conventional cITP coupled to mass spectrometry (MS), trace peptides are focused in 
adjacent bands. This causes several adjacent peptides to enter the MS all at once, resulting 
in multiple peptide mass spectra and signal discrimination due to ion suppression. In this 
paper, we explore the use of spacer molecules to overcome this complication of cITP-MS. 
Carrier ampholytes (CA), which are normally used to generate pH gradients in (C)IEF, can 
act as spacer compounds in cITP. In this way the peptide bands are separated from each 
other, making MS analysis of pure peptides possible. As an example the analysis of a set of 
6 model peptides as well as a tryptic digest of bovine serum albumine (BSA) is reported. 





Qualitative and quantitative information about the concentration of trace compounds 
such as peptides, for example in plasma, is highly important for health sciences, since they 
often are markers for diseases [1]. Counting all proteins and peptides of all variations and 
origins, the plasma proteome is believed to contain as much as 1 million molecule species. 
Their physiological range spans from 35-40 mg/mL in the case of the protein serum albumin 
and 0-5 pg/mL in the case of the peptide interleukin 6 [2]. The role of peptides in important 
biological processes such as inflammatory response, tumour biology and endocrine processes 
has been established [3], so there is a great demand for knowledge about human peptides 
and their functions. Progress is mainly limited due to the lack of techniques that enable 
a comprehensive peptide analysis [4], especially at very low concentrations where many 
relevant peptides occur (pg/mL). Nowadays, (nano)LC and CZE coupled to MS are the 
two most common techniques used for peptide analysis. However, both approaches have 
limitations regarding their dynamic range and limit of detection (LOD). 
A benefit of CE-based systems is the simplicity of the system, i.e. a disturbed CE-system 
is repaired by just replacing the capillary, which is cheap and not time-consuming. On 
the contrary, troubleshooting in a disturbed nano-LC system can be complex [5], time-
consuming and maintenance costs can become high.
CZE coupled to electrospray ionisation MS (ESI-MS) offers high separation power, 
high mass sensitivity and structural information about the peptides, but due to the low 
loadability of CZE this technique suffers from high sample concentration LOD values. 
For this reason and for the fact that CZE is just as chromatography in essence a diluting 
separation technique, very low-abundant peptides are not detected. This can be partly 
overcome by using appropriate sample pretreatment, making the overall analytical process 
more complex.
However, cITP offers a way to increase the analyte concentrations during separation. 
Thanks to a discontinuous electrolyte system consisting of a leading electrolyte (LE) and a 
terminating electrolyte (TE), in cITP the ultimate migration velocity of the analyte ions is 
the same in the whole capillary. The choice for leading and terminating electrolytes depends 
on the mobilities of the analytes that are to be studied; i.e. a suitable ‘isotachophoretic 
window’ should be created. In the sample plug, which is injected between LE and TE, 
analytes are arranged according to their electrophoretic mobilities. As a result, the peptides 




an improvement in detectability via extended loadability. 
According to Kohlrausch’s regulation function (Equation 1), the concentration of ion 
a (the analyte) is dependent on the concentration of the preceding ion l (the leading ion). 
1)  
In this equation, Ca and Cl are the molar analyte and LE concentrations, respectively, and 
μa, μr and μl are the electrophoretic mobilities of the analyte a, counter ion r and the leading 
ion l, respectively. The effect of this process is concentration of sample compounds with 
concentrations below the LE concentration, while on the other hand sample compounds 
present at concentrations higher than LE will be diluted. As a consequence, the dyamic range 
of cITP-MS is increased compared to LC- or CZE-MS, enabling detection of low as well as 
the high abundant compounds in one single analysis. As stated above, the concentrations 
of the peptidome span a dynamic range of 10 orders of magnitude [2]. The concentration 
factor that can be achieved using cITP can be as high as 106 times [6]. In addition to the 
concentrating effect, the diffusion of analytes is counter-acted, since the analyte bands are 
self-sharpening as they have each their own electric field strengths. And finally, cITP can aid 
in sample clean-up by choosing suitable TE and LE so that interfering matrix compounds 
having higher or lower electrophoretic mobilities than the peptides investigated can be 
excluded from the separation. In literature a clear explanation of ITP is given by Holloway 
and Trautschold [7] and Petr et al [8].
The detection method of choice for peptides (and proteins) nowadays is MS [9]. Using 
MS, mass information as well as structural information about peptides can be obtained, 
enabling quick identification of peptides and discovery of new peptide species. A drawback 
of MS is the fact that, when more compounds are present at the same time during ESI, 
ion suppression compromises the linear response of the analytes, which makes reliable 
quantitation problematic [10].
Coupling cITP with MS is not as straightforward as for example CZE-MS or LC-MS, 
since in the isotachophoretic process the analytes are focused in directly adjacent zones 
instead of physically separated zones. This creates mixed zones at the boundaries between 
the analyte zones [11], which was already noted in the same time frame as the invention of 
ESI in 1989 [12]. In these mixed zones, ion suppression takes place and as a consequence 
quantitative determinations are affected, especially in the case of low analyte concentrations, 
when the zones are prone to collapse and mix fully [13]. This is a severe drawback of cITP-
       
          





MS for trace analysis with small sample volumes. According to Equation 1, the very low-
abundant peptides are strongly concentrated, resulting in very narrow bands. These narrow 
bands will enter the MS at virtually the same time. As a consequence, the separation is lost 
and therefore ion suppression between the analytes may occur during ESI, making reliable 
quantitation cumbersome [13].
For these reasons, the direct coupling of cITP with MS has not often been utilised yet 
and instead cITP-MS has mostly been applied in combination with CZE [14], via directly 
coupled cITP-CZE [15,16,17] or via transient isotachophoresis coupled to CZE (tITP-
CZE) [18,19,20, 21]. Direct comparison of analyses of the plasma levels of the peptides 
angiotensin II and gonadorelin with tITP-CZE-UV and LC-UV has already shown that 
tITP-CZE-UV is superior to LC-UV in terms of concentration LOD [22]. In [23], 
preparative tITP-CZE and strong cation exchange solid phase extraction (SCX-SPE) as first 
dimension in a twodimensional shotgun proteomics set-up were compared. The second 
dimension was nano-reversed phase liquid chromatography coupled to MS in both cases. 
Analysis of glioblastoma-derived cancer stem cells demonstrated that tITP-CZE achieved 
superior performance in total peptide, distinct peptide and distinct protein identifications. 
Moreover, its analytical reproducibility was good. The authors conclude that with the help 
of tITP-CZE multidimensional proteomics platforms can mine deeper into the proteome 
and the technology is expected to serve as a critical component in the overall toolset required 
for biomarker discovery in proteomics.
From a CZE perspective, the combination with cITP means an improvement, but from 
the cITP perspective the combination with CZE means sacrificing two of its major benefits, 
i.e. the self-correcting ability of the analyte zones and the high loadability. It is desirable 
for higher resolution as well as the LOD that the isotachophoretic process is maintained 
until the sample is infused into the MS, because, CZE starts as soon as the zone-sharpening 
isotachophoretic process is aborted, implying that zone broadening by diffusion inherent 
to CZE occurs. To be able to perform cITP coupled directly to MS detection, we explored 
the use of spacer molecules. These will be positioned between the different isotachophoretic 
peptide zones, preventing that several peptide bands enter the MS at the same time. To 
demonstrate this approach, experiments with carrier ampholytes (CA) as spacer compounds 
were carried out.
CA are mixtures of many amphoteric molecule species that have slightly different iso-
electric points. Originally, they were designed to generate pH-gradients in IEF and consisted 




commercially available CA used in this research consisted of the products of a copolymerisation 
reaction of amines, amino acids and dipeptides in epichlorohydrin [25].  Since CA are 
complex mixtures of molecules, a wide range of electrophoretic mobilities is present. In 
a cITP separation of peptides with CA present, both should behave electrophoretically in 
a comparable way, in order to let the CA end up as spacers between the peptides. Since 
hundreds of CA species are present, the chance that bands are being positioned between the 
peptides is expected to be high. For cITP-MS of proteins, it has already been shown that CA 
act as spacer molecules between the protein zones [26], while for cITP-UV the use of CA 
as spacer compounds has been shown for the analysis of lipoproteins [27]. Inorganic acids, 
organic acids and amino acids were used as spacer molecules in cITP-UV analysis of humic 
acids [28], while 2-chloropropionic, glyoxylic and levulinic acids were used as spacers in 
cITP of ribonucleotides [29]. Moreover, a procedure has been described to choose suitable 
amino acids and dipeptides as spacers for cITP of various anionic species via a calculation 
that takes isotachophoretic steady-state parameters based on the ionic mobilities and pK 
values of the separated compounds and migration order into account [30]. 
However, CA are known to disturb MS detection. For example, in cIEF 0.2% CA added 
to the sample causes a loss in peptide MS signal of 15-45% [31]. In cITP, this effect is 
expected to be less present or even absent because the peptides and CA are better separated 
from each other and, more importantly, according to Kohlrausch’ regulation function the 
CA concentration will never exceed the LE concentration. As a result, when a typical LE 
concentration (5-10 mM) is used, the maximum CA concentration that is reached during 
ITP should have a limited influence on the ionisation efficiency of the co-introduced 
peptides. Adding a higher amount of CA will not affect their concentration in the various 
ITP bands, only their bands will be broader.
In this study, different from the approaches described in literature so far, we focus on the 
direct coupling of cITP to MS with the help of CA as spacer molecules. This is demonstrated 
with peptides as model compounds. Furthermore, the potential of this approach for bio-
analysis is investigated with the cITP-MS analysis of a digest of BSA.
2.  Materials and methods
2.1 Equipment
cITP was carried out in untreated fused silica capillaries using a programmable PrinCE 




capillaries (ID 75 μm, OD 320 μm) were purchased from Bester (Bester B.V., Amstelveen, 
The Netherlands). Elutions from solid phase extractions were freeze-dried in a Zibus Vaco 
I freeze-dryer (Zirbus Technology, Bad Grund, Germany) under vacuum that was applied 
with an Alcatel 2008A vacuum pump (Alcatel Vacuum Products, Hingham, MA, USA). 
Mass spectrometric experiments were carried out on a Bruker Daltonics MicrOTOF mass 
spectrometer (Bruker Daltonics, Bremen, Germany) using a CE-MS electrospray interface 
supplied by Agilent Technologies (Amstelveen, The Netherlands). 
2.2 Chemicals
All reagents were of analytical grade or higher. A Millipore Q-guard water purifying 
system (Billerica, MA, USA) was used to obtain pure water,  ACN was obtained from 
Biosolve (Valkenswaard, The Netherlands), formic acid from Acros Organics (Bridgewater, 
NJ, USA), ammonium acetate, ε-aminocaproic acid, BSA and trypsin from Sigma (St. 
Louis, MO, USA), acetic acid and sodium hydroxide from JT Baker (Philipsburg, NJ, 
USA) and the model peptides from Genscript Corporation (Piscataway, NJ, USA). The 
CA mixture (Pharmalyte 3-10) was purchased from Amersham Pharmacia Biotech AB 
(Uppsala, Sweden).
2.3 Capillary electrophoresis
Prior to every cITP experiment, the separation capillary (length 100 cm) was conditioned 
by subsequently flushing for 15 min with 1 M NaOH, 15 min with 0.1 M NaOH and 
15 min with LE. The LE consisted of 5 mM ammonium acetate and the TE of 10 mM 
ε-aminocaproic acid. LE, TE and sample were adjusted to pH 3 with acetic acid [18,19]. 
Hence, the leading ion was NH4
+ and protonated ε-aminocaproic acid functioned as the 
terminating ion. Hydrodynamic injection was applied to fill the capillary with the electrolytes 
and sample. 
Prior to loading a sample for cITP analysis, CA were added to the sample. A typical 
cITP procedure consisted of filling the capillary with LE, loading a sample plug and finally 
injecting a TE plug. The sample plug as well as the TE plug comprised roughly 5 % of the 
capillary volume, corresponding with around 0.22 μL. Since the BSA peptides occurred in 
low concentrations in the sample, a larger amount of sample was injected in order to obtain 
broader, better detectable BSA peptide zones: 25% of the capillary was filled (1.1 μL). To 




effect of the electrospray) was completed, a higher backpressure than in the experiments 
with model peptides was used. The counter pressure was generated by a hydrostatic pressure 
(standard difference in height of inlet and outlet of 35 cm (inlet lower) combined with a 
negative pressure (±11 mbar in the case of experiments with model peptides and -20 mbar in 
the case of BSA digest) at the capillary inlet.  While applying counter pressure a separation 
voltage of 24 kV was applied. After 60 min of counter pressure, the sample was allowed to 
enter the MS by applying 50 mbar pressure at the capillary inlet, while maintaining the ITP 
voltage. 
cIEF-experiments were carried out with 10 mM NaOH as anolyte and 1% FA as catholyte 
in the same capillaries as were used for cITP. After flushing the capillary with the anolyte, a 
sample plug consisting of the model peptides and 2% of CA was injected hydrodynamically, 
followed by catholyte. Then, the analytes and CA were allowed to focus for 30 min before 
the sample was transferred to the MS using a hydrodynamic pressure of 50 mbar generated 
by the injector, while maintaining the IEF voltage.
CZE was carried out with 1% acetic acid as background electrolyte. The capillary was 
filled for ±1% with sample, after which high voltage and 50 mbar hydrodynamic pressure 
were applied for separation and transfer to the MS.
2.4 Mass spectrometry
The coupling of cITP to the MS was based on a pre-fabricated CE coupling sheath-liquid 
assisted grounded spray source delivered by Agilent Technologies (Agilent Technologies, 
Amstelveen, The Netherlands). The sheath liquid consisted of a 50/50 mixture of ACN and 
0.2% formic acid and the sheath liquid flow rate was set at 3 μL/min.
Identification of peptides was based on matching of the known masses of the target 
peptides with the mass information obtained with the MS. To decrease noise levels, all ion 
traces were processed with Gaussian smoothing (value 4.03) using the software delivered 
with the MicrOTOF MS by Bruker Daltonics (Bruker Daltonics MicrOTOF DataAnalysis 
version 3.3). Mass spectra were processed with background subtraction (using an MS 
spectrum taken from the TE without any other added component) to remove some neutral 
contaminants in the TE that were detected throughout the whole sample.
2.5 BSA digestion and sample clean-up




was pretreated with S-methyl methanethiosulfonate (MMTS) and tris(2-carboxyethyl)
phosphine (TCEP) to break and reduce disulfide bonds, respectively. The digested proteins 
were purified by SPE using TopTip© pipette tips (Glygen Corp., Maryland, USA) filled with 
a small amount of Poros RP-2 SPE material. In brief, the material was wetted with ACN, 
then equilibrated with 0.1% formic acid after which the sample (acidified to pH 3 with 
formic acid) was applied. Then, the bound analytes were washed with 0.1% formic acid, 
after which elution was achieved with a 60/40 mixture of ACN and 0.1% formic acid. Next, 
the eluent was freeze-dried and resuspended in 10 mM TE. The proteomic tool Peptide 
Mass on www.expasy.ch was used to forecast masses of peptides after digestion. 
3. Results and discussion
3.1 Proof-of-principle using model peptides
First, an experiment was done to confirm that the chosen LE and TE were suitable for 
the cITP of peptides. This was done by using two LE concentrations, 5 mM and 20 mM, 
in a cITP separation of the 3 model peptides. When using 20 mM, the peptide zones were 
higher and narrower than with 5 mM LE (Fig. 2.1), which is in agreement with ITP theory. 
Therefore, the combination of protonated ε-aminocaproic acid as terminating ion and NH4
+ 
as leading ion appeared to be suitable for cITP of peptides. Moreover, a direct comparison 
of CZE with ITP was conducted, which showed considerably higher peptide zones when 
using the two-buffer system consisting of the leader ammonium acetate and the terminating 
ion protonated ε-aminocaproic acid (data not shown), while  the initial concentrations of 
the injected samples were equal. On top of this, a series of experiments has been carried out 
in which the sample loading was varied. These experiments resulted in isotachopherograms 
with peptide zones of different widths, but of equal concentration (zone heigths) for the 
different sample loadings (data not shown). According to the ion concentration regulating 
principle of Kohlrausch (Equation 1) an increase of analyte amount results in broader zones, 
but not in higher concentrations. Moreover, the current profile was typical for ITP, starting 
at ± 12.5 μA and decreasing to reach a stable plateau at ± 5 μA after 30 min. Based on the 




Next, the influence of CA on the isotachophoretic behaviour of a set of 6 model peptides 
(Table 2.1) was examined by comparing the isotachopherograms as obtained with different 
concentrations of CA (Fig. 2.2). The concentration of the model peptides was 62.5 μg/
mL, corresponding to a molar concentration range of 48-110 μM and 10-25 pmol per 
injected peptide. As expected, the addition of CA to an academic mixture of model peptides 
improved the separation of the peptides (Fig. 2.2). 
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Figure 2.1 Comparison of cITP separations of, in migration order, bradykinin (1-5), bradykinin (1-6) and 
angiotensin 2 (3-8) with 5 mM and 20 mM NH4
+ as LE.
Table 2.1 The analysed model peptides, their physicochemical 
properties and migration orders in cIEF, CZE and cITP.
 
PEPTIDE DETAILS MIGRATION ORDER 
Name Sequence [M + H]+ pI cIEF CZE cITP 
Thymopentin RKDVY 680.76 8.88 4 1 1 
Bradykinin RPPGFSPFR 1061.20 11.97 1 2 2 
Angiotensin 1 DRVYIHPFHL 1297.48 7.38 5 3 3 
Bradykinin (1-5) RPPGF 573.66 10.00 2/3 4/5 4 
Bradykinin (1-6) RPPGFS 660.80 10.00 2/3 4/5 5 




Without CA, thymopentin, bradykinin and angiotensin I were not separated, while in 
the presence of 1% CA they were. When 10% CA was present, the peptide zones were more 
separated compared to the presence of 1% carrier ampholyte. With only one exception, 
the mass spectra of all peptides (Fig. 2.2 A-G) revealed that each zone contained only one 
peptide. For example, whereas without CA the model peptides bradykinin and thymopentin 
were not separated at all, after addition of 1 or 10% CA, separated single peptide zones were 
observed. Two peptides could hardly be separated at all, with or without CA, i.e. bradykinin 
(1-5) and bradykinin (1-6) (Fig. 2.2 F). These peptides differ by only one amino acid (see 
Table 2.1) and as a consequence apparently have almost the same electrophoretic mobility. 
Adding CA did not have a spacing effect between the bradykinin (1-5)/bradykinin (1-6) zone 
and the angiotensin II 3-8 zone. Apparently the CA mix did not contain compounds with 
the required electrophoretic mobilities to act as spacer between these peptides. In the mass 
spectra of the isotachopherogram it can be seen that most CA are migrating ahead of the 
peptides (Fig. 2.2 A). Between bradykinin and thymopentin, only one CA species is observed 
(Fig. 2.2 C), demonstrating that the majority of the electrophoretic mobilities present in the 
CA mixture are not in the range of the electrophoretic mobilities of the peptides. In the 
absence of CA, some peptide zones are not adjacent, because some contaminants present in 
the academic mixture or in the buffer were concentrated too. These contaminants were not 
detected by the MS, possibly because their masses were outside the tuning range of the MS 
(300-1500 m/z). 
It is reasonable to suspect that the addition of CA to the peptide mixture results in IEF 
rather than ITP, since CA were originally designed for IEF separations. To exclude this 
possibility, a cIEF experiment was performed, which resulted, as expected, in a separation 
according to the iso-electric points of the peptides (Table 2.1). The peak order in CZE 
corresponded with the electrophoretic mobilities of the peptides (Table 2.1), excluding the 
option of a hybrid IEF-ITP separation too. Moreover, in IEF the principle of Kohlrausch 
does not apply due to the absence of leading and terminating ion zones. This was supported 
by a comparison between the isotachopherograms with 1% CA and 10% (Fig. 2.2); when 
more CA were present, the zones were further apart.  
In IEF separations, ion concentrations are not regulated by the LE concentration which 
in practice often results in peptide or protein precipitation at their pI during focusing because 
too high concentrations are generated [31], instead of the broader zones with regulated 
concentrations that would be generated in cITP. 




intensity and differences in releative zone heights between the peptides when more CA are 
added. This is due to the nature of the CA mixture, which will be discussed in the next 
section.
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Figure 2.2 Reconstructed ion cITP-MS electropherograms of model peptides and corresponding mass spectra. 
(I) no CA added, (II) 1% CA added, (III) 10% added to sample. (A-G) MS spectra of zones in III. *) = TE 





3.2 CA as spacers in cIPT-MS of complex biosamples
The initial concentration of BSA before digestion was 4.9 μM. After digestion, RP-SPE 
and freeze-drying, the peptides were diluted 10 times with TE so that the final concentration 
was 490 nM in the case of complete recovery. This corresponds to around 500 fmol injected 
BSA digest. 
In Fig. 2.3, the results of the analysis of the BSA peptides without CA are shown. Since 
the concentration of the peptides is low, they are concentrated in adjacent narrow zones that 
collapse easily [13] and in consequence enter the MS virtually simultaneously in one plug. 
In a mass spectrum taken from this plug, it can be observed that many peptides are present 
indeed. 
After adding 1% CA to the sample, the peptides are more separated and spread in the 
resulting isotachopherogram. In Fig. 2.4 it can be seen that five peptides are fully separated 
and single-peptide mass spectra could be acquired, of which four were BSA peptides and 
one was an unknown compound, most probably a trypsin peptide, keratin peptide or a BSA 
peptide that originated from hydrolysis instead of trypsin digestion. The same five peptides 
were also detected in the bulk of co-migrating peptides when no CA were added. So far, 
only these five separated peptides were found. When 10% CA was present during cITP, 
no peptides could be observed at all (data not shown). It should be noted that since lower 
backpressure was used during these experiments, migration times and zone lengths in Fig. 
2.3 and 2.4 were increased in comparison with Fig. 2.2..
A big disadvantage of the CA mixture used in this study was that the composition of the 
mixture is not exactly known, as it is a commercial product, meaning that the production 
and product composition is proprietary and not disclosed. This is actually also true for 
other commercial CA mixtures. However, a recent series of studies have provided more 
insight into the composition of commercial CA mixtures [33]. The CA were separated by 
preparative iso-electric focusing using a Rotofor device and the composition of the obtained 
fractions was characterised using MS. It appeared that, Pharmalyte pH 2.5-10.5 consists of 
hundreds of compounds in the mass range of 150-1179. However, it was also discovered 
that a significant part of the CA in Pharmalyte mixtures were poorly functioning as CA. For 
Pharmalyte 8-10.5 this was estimated to be as much as 50% of all the detected ‘CA’. This 
was concluded from the fact that no focusing took place, since a continuous distribution 
along the entire pH gradient in the Rotofor was observed [33]. The CA mixture that was 
used in our study, Pharmalyte 3-10, also contained as many as hundreds of molecule species. 




electric field, the fact that some components were not migrating at all can only be explained 
by the conclusion that these molecules were neutral. These findings can most likely explain 
the poor results that were obtained from the BSA digest analysis in our study. Since the 
sample is confined between the LE and TE zone and due to the very low EOF at this 
(low) pH, the neutral components of the CA mixture will be inseparable from the peptides 
by electrophoresis once they are mixed with the sample. These neutral CA cause a high 
background as well as ion suppression. 
In the analysis of academic mixtures of model peptides they already caused a severe signal 
decrease, from 5.2 x 104 AU for angiotensin II 3-8 when no CA were added, to 4.2 x 103 
AU when 10% of CA were added (Fig. 2.2). This negative influence of impurities in the CA 
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Figure 2.3 cITP-MS of BSA peptides without CA: (I) total ion count isotachopherogram, (II) reconstructed ion 
isotachopherograms of selected peptides, (III) mass spectrum of the highest peptide signal at 104 min; masses 




mixture was not equal for every zone, since the relative zone height differed between 0, 1 and 
10% added CA, as can be observed in Fig. 2.2. 
To infuse the sample into the MS, some hydrodynamic pressure had to be used, due 
to the aforementioned very low EOF, which inevitably caused some zone broadening. 
When academic mixtures with relatively high analyte concentrations were injected, broad 
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Figure 2.4 cITP -MS of BSA peptides containing 1% CA: I) total ion count isotachopherogram, II) reconstructed 
ion isotachopherograms of selected peptides, (A) mass spectrum of CA, mass spectra of BSA peptides (B) 
LSQKFPK, (C) SEIAHR, (D) VASLR, mass spectra of (E) unknown molecule species and (F) mass BSA peptide 




due to zone broadening. However, when the peptide zones are narrower, as was the case 
with the BSA digest, a little zone broadening already causes a severe decrease of signal. In 
combination with a high background this results in a poor bioanalytical performance.
We have demonstrated that it is possible to physically separate peptide analyte zones 
by mixing the sample with spacer molecules, making a consecutive zone broadening step 
such as CZE unnecesary. However, due to the severe contamination in the CA mixture, 
the overall performance of the developed cITP-MS method was not satisfactory yet, and 
just a few peptides were detected in a complex biosample. To obtain better results, more 
suitable spacer compounds should be developed. This spacer compound mixture should 
meet two main criteria. First, such a mixture should contain a large and continuous gradient 
of electrophoretic mobilities that are close to peptide electrophoretic mobilities in order have 
a maximal chance of spacers between the peptide zones. Secondly, the spacer compounds 
should not interfere with the ionisation of the peptides during ESI to avoid ion suppression 
of the peptide signals. This can be achieved by choosing compounds that are more polar and 
hydrophilic than peptides. Polar compounds have a lower surface activity and therefore tend 
to be on the inner side of the spray droplets during ESI and therefore they ionise worse and 
cause less ion suppression [34]. 
4. Concluding remarks
In this paper, we explored the use of spacer compounds to couple cITP directly to MS. 
We have shown that it is possible to physically separate and detect peptide analyte zones 
in cITP-MS after when spacer molecules are added to the sample before injection. With 
this approach, we were able to detect sub-micromolar peptide concentrations in a complex 
sample, in single-analyte mass spectra. However, especially in the analysis of the more 
complex sample with lower peptide concentrations we encountered a severe drawback of CA 
as spacer molecules: CA mixtures appeared to be ill-defined mixtures with a lot of disturbing 
contaminations present. To be able to detect sub-nanomolar peptide concentrations, i.e. for 
bio-analysis, there is a demand for more suitable spacer compounds. Future research will be 
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In this research paper we show that capillary electroextraction (cEE) is capable of fast 
on-line peptide concentration and that it can be coupled on-line to LC-MS to result in a 
fast and sensitive method. EE takes place when an electric field is applied in a two-phase 
liquid-liquid system. Sample ions in the organic phase migrate very fast into the aqueous 
phase and are concentrated in a small zone. In this work, cEE of peptides is developed and 
coupled on-line to LC-MS via a switching valve. Comparison of 10 min of cEE-LC-MS 
with a conventional LC-MS injection showed more than 100-fold increased peak heights. 
Good calibration curves of five model peptides in the range of 0.05 - 5 μM were obtained. 
The linearity was good (R2 values between 0.984 and 0.996) and relative standard deviations 
ranged from 5 % at the highest to 25 % at the lowest concentration (n=3). The LOD of 
bradykinin, angiotensin I converting enzyme inhibitor and angiotensin I were in the low nM 
range. Analysis of a tryptic digest of eight model proteins resulted in more than 170 peptides, 
without bias for pI or hydrophilicity. Urine analysis is demonstrated, resulting in a LOD 
around 0.04 μM urine for tryptic cytochrome C peptides spiked to urine and an increase 
of 42% in the number of chromatographic peaks compared to conventional LC-MS. In 
summary, cEE-LC-MS is a fast electrophoresis-driven sample preconcentration technique 





For several decades it is known that applying an electric field in solvent extraction 
procedures enhances mass transfer from one phase into the other. This process is sometimes 
referred to as two-phase electrophoresis [1-5], but more conveniently called ‘electroextraction’ 
(EE), a term that was first proposed in the early 1990s by Stichlmair et al [6]. Initially, 
EE has been developed as a purification technique in the field of chemical engineering, to 
enhance product yields [1-5, 7, 8]. However, around a decade ago Van der Vlis et al. adapted 
liquid-liquid EE for analytical purposes, using ethyl acetate (EtOAc) as organic phase and 
performing EE of test solutions in capillaries (cEE) [9-11]. Despite the promising results 
that were presented in these publications, analytical cEE has not been developed further 
since and no bio-analytical applications have been published. Recently, the potential of EE 
and related techniques received renewed attention via review papers on electrochemically 
modulated extraction methods [12] and electric field-amplified transport across phase 
boundaries [13]. 
When an electric field is applied in a two-phase liquid-liquid system that consists of a low 
conductive organic phase and a high conductive aqueous phase, charged compounds that 
are in the organic phase will migrate fast towards the aqueous phase. As soon as the aqueous 
phase is entered, migration speed decreases dramatically, causing analyte concentration. EE 
offers enhanced selectivity, as either cations or anions are extracted, while neutral compounds 
will largely remain behind since they only migrate to the aqueous phase by passive diffusion. 
In this set-up, only the electric field on the low-conductivity side of the interface will be of 
importance for ion migration [8]. To achieve a sample concentration effect, the analytes 
should therefore dissolve in the organic phase. A prerequisite of the organic phase is that 
it has some conductivity to enable ion transfer. Pure EtOAc hardly conducts current and 
therefore is not suitable for EE. However, when saturated, EtOAc contains 3.5% (v/v) water, 
which allows the presence of ions. The solubility of the small protein egg white lysozyme has 
been reported to be good (10 mg/mL) in EtOAc, [14] and some enzyme activities are even 
enhanced in an organic environment [15]. 
The major difference between cEE and conventional field amplified sample stacking 
(FASS) [16-19] is, thanks to the using of two immiscible liquid phases, the presence of a 
liquid-liquid interface. The liquid-liquid interface limits the influence of thermal currents 
caused by convection. When only one phase is present, as in FASS, thermal currents caused 




system convection is constrained to a single phase by a physical border [6]. Therefore, zone 
broadening during EE is limited [6, 8]. Moreover, since very high electric fields strengths 
occur in the organic phase, EE is fast. 
In this research paper, the cEE process was characterised by studying the current 
behaviour using ammonium as model cation and crystal violet for visualisation. Then, cEE 
of peptides was developed and coupled to LC-MS. The resulting cEE-LC-MS procedure was 
successfully applied to the analysis of a tryptic digest of several model proteins and urine. To 
our best knowledge, the application of cEE to biomolecules in complex biological samples 
has not reported before in literature.
2. Experimental
2.1 Chemicals
All reagents were of analytical grade or higher. A Millipore Q-guard water purifying 
system (Billerica, MA, USA) was used to obtain pure water. Acetonitrile (ACN), EtOAc 
and formic acid (FA) were obtained from Biosolve (Valkenswaard, The Netherlands), 
ammonium acetate, ammonium bicarbonate, crystal violet, model proteins, proteomics 
grade trypsin, dithiothreitol, iodoacetic acid and glycine from Sigma (St. Louis, MO, USA), 
acetic acid and sodium hydroxide from JT Baker (Philipsburg, NJ, USA) and the model 
peptides (bradykinin 1-5, mass 572; bradykinin 1-6, mass 659; angiotensin I converting 
enzyme inhibitor (alias [Des-Pro2]-Bradykinin), mass 963; thymopentin, mass 679; 
bradykinin, mass 1060; angiotensin I, mass 1296 and substance P, mass 1347) from 
Genscript Corporation (Piscataway, NJ, USA).
2.2 Equipment and techniques
2.2.1  First EE set-up
To study the EE process, experiments have been carried out in a custom-made EE 
device (Fig. 3.1A). This device consisted of a vial (height: 108 mm, ID: 15 mm, material: 
polychlorotrifluorethylene (PCTFE), thickness 3 mm) with a conical bottom (angle 28˚) 
with two threaded inlets where a platinum electrode and a capillary were fixed with finger-
tight nuts (Standard Head Fitting for 360 μM OD tubing, Upchurch Scientific, Oak 
Harbor, WA, USA). The capillary (OD: 400 μm, ID: 320 μm, material: fused silica) served 




Ltd., Las Vegas, NV, USA). The bottom electrode was grounded. The conical bottom 
enabled extraction into a small aqueous phase volume. The electric circuit was closed with 
a gold coated anode (to minimise reduction/oxidation reactions) with a flat circled end 
contacting exactly the whole surface of the organic phase, ensuring all ions to be exposed 
to the electric field. High voltage was applied with a Spellman High Voltage Power Supply 
(Spellman, Hauppauge, NY, USA). Electric current was measured with a simple multimeter 
(Voltcraft, Oldenzaal, The Netherlands) and conductivity with a conductivity meter from 
Hanna Instruments (type HI 8733, Woonsocket, RI, USA).
Samples taken prior to and after EE were freeze-dried in a Zirbus Vaco I freeze-dryer 
(Zirbus Technology, Bad Grund, Germany) under vacuum that was applied with an Alcatel 
2008A vacuum pump (Alcatel Vacuum Products, Hingham, MA, USA).
2.2.2  cEE-MS
cEE was carried out in an Agilent Technologies 1600 series CE apparatus (Agilent 
Technologies, Santa Clara, CA, USA). An untreated fused silica capillary (65 cm, 75 μm ID) 
+
grounded capillary 









A: first EE set-up B: capillary EE
Figure 3.1 A) Schematic set-up of EE in the laboratory made device. B) Sample introduction set-up of capillary 




was filled with aqueous phase and dipped via a hollow electrode in the organic phase that 
contained the charged analytes. The organic phase (50 μL) was in a flat-bottom glass insert 
vial of 30.75 x 5 mm (Micro-insert, Bester BV, Amsterdam, The Netherlands). The capillary 
outlet was grounded via the spray source, while the organic phase was in contact with the 
anode. No height difference between capillary inlet and outlet was present.  The capillary 
inlet was located close to the vial bottom (inner diameter 3 mm) and the hollow electrode tip 
close to the liquid surface (Fig. 3.1B), so the electric field was present throughout a maximal 
part of the organic phase. The extraction volume was estimated to be 14 μL (a cone with 
a length of 6 mm and a base diameter of 3 mm) by was visually observing an extraction of 
crystal violet, which showed depletion in the expected area. MS experiments were carried out 
on a Bruker Daltonics MicrOTOF MS (Bruker Daltonics, Bremen, Germany). Coupling 
of cEE to direct infusion (DI) was achieved using a sheath-liquid assisted grounded spray 
source supplied by Agilent Technologies (part number G160760001). The sheath liquid 
(50%/50% (v/v) ACN and 0.2% FA, 3 μL/min) served to close the electric circuit and for 
good spray. Further spray settings were: end-plate offset -529 V, capillary voltage -1762 V, 
nebuliser gas pressure 0.4 bar, dry gas flow 4.0 L/min and dry temperature 200 ˚C. The 
recorded mass range was 200-1200 m/z.
 
2.2.3  Liquid chromatography
LC was carried out with an Agilent Technologies 1200 series μHPLC apparatus, equipped 
with a ZORBAX SB-C18 (5 μm, 150 x 0.5 mm) capillary HPLC column, also purchased 
from Agilent Technologies. A 20 μL/min gradient elution was employed (solvent A: 0.1% 
FA in water, solvent B: 0.08% FA in ACN), starting at 0% B and ending after 30 min 
at 35%, unless otherwise stated. Next, the column was conditioned for 5 min with 95% 
solvent B and 5 min with 100% solvent A. On each day, a blank run was performed first.
   
2.2.4  Interface for coupling cEE and LC
Coupling of EE with LC was facilitated with a bio-compatible 6-port 2-way switching 
valve (Cheminert® HPLC injection valve model C2-1246, Valco Instruments, Houston, TX, 
USA). The rotor consisted of polyaryletherketone (PAEK). In this switching valve, the liquid 
has no contact with metal parts, preventing short circuiting and unsafe working conditions. 





2.2.5  On-line cEE-LC-MS
Coupling of cEE-LC to the time-of-flight (TOF) MS detector was realised with a 
conventional electrospray needle that was provided with TOF-MS (Bruker Daltonics) part 
number EN8389). The spray settings were as described in section 2.2, except nebuliser 
gas pressure (1.0 bar) and dry gas flow (8.0 L/min) to cope with the higher flow rate. In 
the case of cEE-LC-MS of digested model proteins, a linear triple quad - ion cyclotron 
resonance - Fourier transform - mass spectrometer (LTQ-ICR-FT-MS) (Thermo, San Jose, 
CA, USA) served as detector, to facilitate peptide identification. LC-MS was achieved with 
a conventional electrospray device delivered by the manufacturer. Spray settings for LTQ-
ICR-FT-MS were: sheath gas flow 15 L/min, source high voltage 3 kV, capillary temperature 
200 ˚C, capillary voltage 30 V and tube lens voltage 155 V. During analysis, the MS 
continuously performed scan cycles in which first a high-resolution (R = 100 000) full scan 
(200-1200 m/z) in profile mode was acquired by the FT-MS, after which MS/MS spectra 
were recorded in centroid mode by the LTQ for the 3 most intense ions (isolation width, 4 
m/z; normalised collision energy, 35%). Dynamic exclusion was enabled (repeat count, 1; 
repeat duration, 30 s; exclusion list size, 500; exclusion duration, 180 s; relative exclusion 
mass width, 5 ppm) as was charge state screening (q = 1-4).
2.2.6  Data analysis/protein identification
Identification of model peptides was based on matching of the known masses with the 
obtained mass information. When MS/MS was performed, a database search was performed 
with the software application Bioworks (version 3.3), using the following settings for peptide 
identification: ΔCN > 0.100, Xcorr versus charge state 1 ≥ 1.80, 2 ≥ 2.50, 3 ≥ 3.50, peptide 
probability < 0.5 and Δppm < 5.0.
2.3  Sample pretreatment
First, a model peptide mixture was diluted twice with 1 mM acetic acid and acidified to 
pH 3 with FA to ensure cationic peptides. Then, EtOAc was saturated with the sample, by 
adding as much as possible without allowing a two-phase system to form. Then, it contained 
2.2 % (v/v). The maximal percentage of 3.5% (v/v) was not reached, most likely because 
some water was already present.
Cytochrome C (horse and human), hemoglobin (human), ribonuclease A (pancreatic 
bovine), lysozym (chicken) and bovine serum albumine were digested using sequence grade 
trypsin. Per protein, 100 μg was digested with 1 μg trypsin in 200 μL 100mM ammonium 




dithiothreitol (4.5 mM) and alkylated with iodoacetic acid (10 mM), as prescribed in [20]. 
After adding FA (2% v/v sample concentration), the digested proteins were purified by SPE 
using TopTip© pipette tips (Glygen Corp., Maryland, US) filled with a small amount of 
Poros Reversed Phase (RP)-2 SPE material. The material was wetted with ACN, equilibrated 
with 2% aqueous FA and the sample was applied. The trapped peptides were washed with 
2% aqueous FA and elution was achieved with 50 μL 70/30 mixture of ACN and 2% 
aqueous FA. Next, 6.25 μL of the eluent was mixed with 110 μL anhydrous EtOAc. 70% 
ACN is better miscible with pure EtOAc (5.6%) than water (2.2%). No precipitation was 
observed. 
Freshly voided urine samples were obtained from adult, healthy volunteers (age 18 to 
29), pooled, acidified with FA (2%), divided in aliquots and stored at -80 ˚C until analysis.
3. Results and discussion
3.1 Description of the electroextraction process
At first, the EE process was characterised using the laboratory-built device (Fig. 3.1A). 
EE is a process of ion fluxes, and therefore the EE process can be followed by monitoring the 
current. The organic phase consisted of 11 mL EtOAc saturated with 10 mM ammonium 
acetate which was first adjusted to pH 3 with FA. After saturation, the EtOAc contained 
0.2 mM ammonium acetate and 0.55 nM FA. The aqueous phase consisted of 100 μL 10 
mM ammonium acetate (adjusted to pH 3 with FA). These phases have a large difference in 
conductivity (0.3 μS/cm and 1150 μS/cm were measured in the donor and acceptor phase, 
respectively). Electric field strengths of 40 kV/m (2.5 kV over 6.25 cm), 24 kV/m (1.5 kV) 
or 16 kV/m (1 kV) were applied for 10 min at similar pH, temperature and phase ratios. 
Ammonium was used as model cation to study EE, for practical reasons (available in large 
amounts, enabling measurable currents), and crystal violet (0.5 μM) was added to the donor 
phase for visualisation of the EE experiment. Due to their very low concentrations FA and 
crystal violet do not contribute significantly to the measured current. Dissociation constants 
of neutral acids and cationic acids can shift in different solvents. However, for ammonium 
this shift is not dramatic in various studied organic solvents such as dimethyl sulphoxide 
and propylene carbonate [21], so it can be assumed that ammonia will be protonated and 
therefore present as ammonium in EtOAc under these experimental conditions. In Fig. 
3.2A, the current profiles are shown. 




decreased exponentially (established by fitting with exponential trend lines) until a stable low 
current (Irest) was reached. Increasing the field strength resulted in a faster current decrease. It 
was observed that the crystal violet immediately started to migrate into the aqueous phase, 
giving rise to a sharp zone and a growing depleted zone at the cathode side in the organic 
phase. Within several minutes, the whole organic phase was depleted into a sharp aqueous 
zone. It was observed that the speed with which the depleted zone was formed decreased 
over time, while simultaneously the current decreased exponentially (Fig. 3.2A). In the 
depleted zone, the removal of ions has caused a lower conductivity and therefore a higher 
electric field strength. Since the applied voltage is constant, the electric field strength that is 
over the organic region that still contains ions will be lowered. As the depleted region grows, 
the electric field strength in the non-depleted zone is decreasing. As a consequence of this 
changing electric field distribution in the EE system, EE takes place in a non-linear manner, 
namely, as shown in Fig. 3.2, exponentially. In Fig. 3.3, the change of electric field strength 
in the different zones is depicted schematically. At the start of EE (I), a uniform electric field 
strength is present in the organic phase. As EE proceeds (II, III, IV), a depleted region with a 
high electric field strength grows. Simultaneously, a slightly decreasing electric field strength 
is present in the aqueous zone, due the increasing amount of ions. Since the conductivity 
difference between the aqueous phase and the organic phase is so large, the small change in 
the aqueous phase has no significant influence on the situation in the organic phase. 
We assumed that the exponential current decrease that was observed can be described as:
1)  
In this equation I(t) is the current as function of time t, I0 the starting current and Irest the 
current that is let through by saturated EtOAc, and β represents the exponential coefficient 
with which the current decreases during EE, therefore called the extraction rate. As can be 
observed in Fig. 3.2A, Irest reached a constant value. To determine values of β with different 
electric field strengths, I(t) was differentiated and the differentiated current I’(t), i.e. dI/dt, of 
the current profiles between 1 and 10 min was plotted versus I(t) - Irest. The resulting slopes 
are the β values, since the differentiated current can be expressed as
2)  
Since EE is a process of depletion, β is negative. The larger the absolute value of β, the 
higher the extraction rate. As can be observed in Fig. 3.2B, rather good linear curves are 
                     




obtained (R2 values 0.99, 0.94 and 0.77 for 40, 24 and 16 kV/m respectively). Increasing 
the applied electric field strength increases the extraction rate. However, when electric field 
strengths above 40 kV/m were applied in this EE set-up, visible instabilities (fluid motion 
and droplet formation) occurred at the liquid-liquid interface, while the current became 
instable and EE failed, which has also been reported in literature [7, 8]. 
A comparison between different ionic strengths in the aqueous phase showed that I0 as 
well as the exponential factor β by which the current decreases were not influenced (data not 
shown). The conductivity difference between the aqueous phase and the organic phase is so 
large, that a 10–fold change in the ionic strength of the aqueous phase has no measurable 
effect. In consequence, EE is robust towards ionic strength variations in the acceptor phase, 
in contrast to field-amplified sample stacking (FASS). When cEE is coupled to LC, the ionic 
strength of the mobile phase (which also serves as aqueous acceptor phase in cEE) does not 
affect the performance of the EE process.
Figure 3.2 A) current profiles (n=3) of EE performed with 3 different electric field strengths B) dI/dt plotted 
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Figure 3.3 Schematic drawing of the changes in electric field strength during EE in the different zones. I, II, 
II and IV depict different time points in the process. During EE, the electric field strength in the organic zone 




3.2 cEE of model peptides
A CE apparatus enables the handling of very small volumes and well-controlled high 
voltage and pressure application. Moreover, in a capillary, much higher electric field strengths 
can be used, since heat is dissipated more efficiently. This makes cEE an attractive option as 
selective sample injection method, as has been described before [9, 10]. On top of this, the 
influence of disturbances at the liquid-liquid interface can be expected to be smaller, since 
the area of the liquid-liquid interface is much smaller [7]. This partly compensates the fact 
that performing EE with a smaller area of the liquid-liquid interface is not advantageous for 
the speed of cEE. Moreover, much higher electric field strengths can be realised when using 
the CE apparatus. When 15 kV is applied, the electric field strength between the liquid-
liquid interface and the electrode tip can be as high as 1.36 x 103 kV/m, which is more than 
30 times higher than in the large-scale EE experiments. 
A very high electric field strength exists in a short plug of low-conductive organic phase 
at the inlet of a capillary that is for the rest filled with higher conductive aqueous solution. 
The shorter the plug length and the larger conductivity difference between the zones will 
be, the larger the electric field strength will be, as was described by Chien and Burgi [17], 
who determined the optimal conditions for in-capillary sample concentration using field 
amplification. 
Based on the above-mentioned aspects, a cEE procedure was developed. Theoretically, 
cEE speed is maximal when the liquid-liquid interface is exactly at the inlet of the capillary. 
However, due to interface instabilities (as described above) as well as EOF mismatch [18] 
it is difficult to fix the interface position at an exact location in the capillary. When the 
interface was too close to the inlet, cEE appeared to be unreliable. Therefore, a small aliquot 
of EtOAc was injected (approx. 2 cm, 3% of the capillary volume, i.e. ~88 nL). During 
cEE, this zone was slowly pushed back into the vial, using back-pressure, which also served 
to counter-effect the influence of the low EOF that still existed at pH 3. Optimisation of 
back-pressure, extraction time and extraction voltage resulted in the following injection 
scheme, analogous to Van der Vlis et al [9]: after a small EtOAc plug was injected by pressure 
(25 mbar) into the capillary, the first minute of cEE was carried out without back-pressure 
to let some more EtOAc enter the capillary by EOF. Then, a back-pressure of 25 mbar was 
applied during the remaining 9 min of the cEE procedure, to slowly push out the EtOAc 
plug without losing the concentrated sample zone. During EE, 15 kV was applied and the 
current profiles were monitored. Between measurements, the fused silica capillary wall was 




To study whether the cEE process is similar to the large-scale EE experiment discussed in 
the previous section, current behaviour during the extraction of 0.5 x 10 -3 mol/L ammonium 
in EtOAc was monitored. Again, the current decreased exponentially (Fig. 3.4A), but much 
faster; the extraction rate β was much higher (Fig. 3.4B) compared to the first EE set-up. In 
Fig. 3.4A, it can be seen that during this period the current is stable and cEE is taking place 
without being disturbed. The current profiles were found to be reproducible.
Three consecutive cEE cycles of bradykinin, angiotensin I, bradykinin 1-5 and substance 
P (concentration in EtOAc 2.1 – 5 nM) were carried out without refilling or shaking of the 
sample vial. Since peptides have lower electrophoretic mobilities than ammonium, longer 
extraction times are needed to achieve peptide depletion, hence an extraction time of 10 min 
was chosen. After each cEE cycle, the sample zone was flushed to the MS using 50 mbar, for 
DI-MS analysis. After the first cEE, more than 96% of each peptide was extracted, while a 
consecutive extraction resulted in a 1 – 3% fraction, and a third consecutive extraction less 
than 0.1% (Table 3.1); percentages were calculated in relation to the sum of the peak areas 
of all three experiments. The total volume in the vial was 50 μL, but the electric field was not 
present throughout this whole volume (as discussed in section 2.2.2). This was confirmed by 
experiments in which a larger sample volume was used: peptide peak areas did not increase. 
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Figure 3. 4  A) cEE current profile of the extraction of 0.5 x 10-3 M ammonium (n=3) B) dI/dt plotted against 




resulted again in high peptide peaks (data not shown). When the effective extraction volume 
is depleted, only peptides that slowly diffuse into the electric field zone are extracted. This 
is only a small amount of peptide in one experiment, because diffusion is a slow process. 
Since only a portion of the organic phase is analysed in the cEE set-up, it is complicated 
to obtain correct recovery data. Altering the shape or position of the electrodes to ensure 
that the electric field is present throughout the whole volume would be a solution, however, 
in the present experimental set-up using a commercial CE autosampler this is difficult to 
realise. Therefore, recovery was determined using the EE device described in section 2.2.1, 
where a sample of organic phase (100 μL) could easily be sampled before and after EE (10 
mL EtOAc, 100 μL 10 mM ammonium acetate adjusted to pH 3 with FA  as aqueous 
phase, 2.1 – 5 nM peptides, 10 min, 5 kV). The samples were evaporated, reconstituted in 
100 μL 50%/50% (v/v) ACN/0.2% FA and analysed with DI-MS at a flow rate of 3 μL/
min. Recoveries (based on measured ion intensities) were 77% for bradykinin, 90% for 
angiotensin 1, 80% for bradykinin 1-5 and 92% for substance P.
3.3 Coupling of cEE to LC-MS
In [11], a cEE needle device was developed to couple cEE to LC. However, a switching 
valve offers a less complicated solution. A 6-port 2-way switching valve with an electrically 
isolated rotor and stator (see experimental section) was used (Fig. 3.5). This valve model has 
proven to be useful as interface for coupling LC-type systems to CE in several designs [22-
24]. The cEE-LC-MS method includes (i) the cEE step; the valve is in the load position, the 
sample loop connects the inlet and outlet of the CE system; (ii) the sample transfer step; after 
cEE, the sample is flushed into the sample loop by applying pressure (~1000 mbar). The 
optimal flush time was determined to be 45 s. A rather large sample loop (5 μL) was chosen 
peak area (%)
peptide 1st EE 2nd EE 3rd EE
bradykinin 98.0 1.4 2.0 1.4 < 0.1
angiotensin I 98.8 1.2 1.2 1.2 < 0.1
bradykinin 1-5 97.7 1.2 2.3 1.2 < 0.1
substance P 96.6 2.8 3.4 2.8 < 0.1
Table 3.1 Result of cEE of 4 model peptides. Percentages were calculated 
relative to the sum of the peak areas of the three consecutive experiments. 




to give the operator a suitable time window to manually switch the valve; (iii) the injection 
step; the valve is switched into the inject position and the sample is injected into the LC 
column. In future work, manual switching can be exchanged with automated switching. 
Band broadening due to the large sample loop volume and application of hydrodynamic 
pressure was overcome by starting the LC gradient with 1 min 100% 0.1% FA (solvent A), 
to allow for peptide trapping on the front of the column. 
An LC-MS run and a cEE-LC-MS run of a test mixture of 5 model peptides (bradykinin 
1-6, bradykinin 1-5, ACIE-bradykinin, bradykinin and angiotensin 1) were compared (Fig. 
3.6). In the LC-MS run, 0.1 μL sample (5 μM per peptide in 70% ACN / 30% 0.1% 
FA) was injected, the recommended maximum for this column when the sample is not 
in solvent A (0.1% FA), as is the case after RP-SPE sample pretreatment. cEE-LC-MS 
resulted in 100 times increased peak areas using the same starting peptide concentrations, 
requiring only 10 min longer analysis time. Peak widths were not impaired and the relative 
peak heights basically remained the same. The LC injection volume was 0.1 μL, while cEE 
depletes maximal 14 μL (section 3.1). The peak heights were about 100 times increased, 
indicating approximately 70% depletion of 14 μL. However, in section 3.2, we showed that 
nearly complete depletion takes place, so apparently the volume where the electric field is 






load position: electroextraction inject position: LC - MS
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Figure 3.5 Schematic drawing of the coupling of cEE to LC. The bold line indicates the active part of the system. 































Figure 3.6 Typical example of the concentrating effect of EE. A) chromatogram resulting from conventional 
LC-MS and B) chromatogram resulting from cEE-LC-MS. When EE was performed, base peak heights were 
increased ~2 orders of magnitude compared to conventional LC-MS. 1) bradykinin 1-5, 2) bradykinin 1-6, 3) 




Calibration curves of electroextraction of 5 peptides from EtOAc were generated, 
containing 5 points (n = 3). As internal standard, thymopentin was used, while the 
concentrations of the 5 other peptides were varied between 0.05 μM and 5 μM in EtOAc, 
corresponding with injected sample amounts between 0.01 and 5 pmol. These levels are 
within biological range [25]. The linearity of cEE-LC-MS after internal standard correction 
is excellent (R2 values between 0.984 – 0.996), the curve intercepts are significantly through 
zero (P values < 0.05) and the repeatability of the calibration curves is good (relative standard 
deviation of the curve slope between 0.73 and 12.0%) (Table 3.2). The relative standard 
deviations of the experimental values ranged between 4.6% at the highest concentration 
to 25.0% at the lowest concentration; the overall mean relative standard deviation of all 
the measurements was 14.7%. At the trace levels from 0.05 μM in EtOAc and below, 
reproducibility decreased dramatically. However, at 20 nM, bradykinin, angiotensin I 
converting enzyme inhibitor and angiotensin I were still detectable with a signal-to-noise 
ratio above 10. In consequence, for these peptides the LOD is estimated to be around 3 nM. 
3.4 Applications
cEE can serve as a fast and simple interface between SPE and LC. Normally, RP-
SPE eluents are freeze-dried and reconstituted in water, which is labour-intensive, time-
consuming and may also introduce an additional error to quantitative results due to sample 
loss by evaporation, adsorption or reconstitution problems. cEE only requires mixing of 
the eluent with EtOAc and is capable of concentrating the analytes in a very small volume 
(< 1 μL)  that can be handled accordingly. Moreover, as mentioned in section 2.3, the 
Peptide R2 slope ± rel. st. dev 
(x 106 AU)
P-value    
intercept
bradykinin  0.996 15.5 ± 0.1% 0.00026
bradykinin 1-5 0.990 0.87 ± 7.9% 0.00026
bradykinin 1-6 0.984 1.03 ± 12.3% 0.000023
angiotensin I 
converting 
enzyme inhibitor 0.991 7.09 ± 1.9%
0.00031
angiotensin 1 0.988 27.5 ± 4.6% 0.0002
Table 3.2 Regression data of the calibration curves of 5 model peptide 




eluent, containing 70% ACN, is better miscible with EtOAc than water (~5.5% instead of 
2.2%), enabling a larger sample amount to be introduced for cEE. When attempting the 
first cEE experiments with biological samples, low recoveries were obtained. Probably, the 
peptides are not entirely in solution in cationic form in the EtOAc phase, possibly due to a 
precipitation reaction with matrix components. Possibly, adding extra components to the 
EtOAc will offer a remedy, this has our future attention.
 
3.4.1 Protein digests
A model protein digestion mixture containing human cytochrome C, horse cytochrome 
C, human haemoglobin, chicken lysozyme, bovine ribonuclease A and bovine serum 
albumin was analysed. Of each protein, the initial amount (prior to SPE), was 12.5 μg, 
corresponding with 0.18 - 1.0 nmol. The amount of digested protein present in one cEE 
experiment was maximal 0.023 - 0.13 nmol. Since the effective extraction volume was ~ 10 
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Figure 3.7 A) cEE-LC-ICR-FT-MS chromatogram of a model protein digest. Gradient: 0 to 50% B in 50 min. 




More than 170 peptides were extracted, separated and identified in one single run. The 
found peptide masses ranged from 500 to 4200 Da, 5 to 39 amino acids. Protein coverage 
was satisfactory: between 48% and 94 %, average 65%. As can be observed in Fig. 3.7, 
peptides with pI values ranging from 4 to 12 were extracted. The GRAVY index is a measure 
for the hydrophobicity of a protein, where lower values represent more hydrophilic peptides 
[26]. In Fig. 3.7, it can be observed that peptides above and below 0 were extracted. Studying 
the peptides that were not found back in this experiment (hence the protein coverage 
percentages below 100), revealed no different pI and GRAVY index range and pattern (data 
not shown). 
3.4.2 Urine analysis
Fig. 3.8 shows a direct comparison between LC-MS and cEE-LC-MS of an SPE eluent 
(70% ACN) of urine spiked with 2 model peptides and cytochrome C digestion (0.5 
μmol/L). In the LC-MS run, the eluent was diluted (5.5 %, i.e. 18 times) with water leading 
to the same analyte start concentrations as when cEE-LC-MS was performed. In a 1 μL 
LC-MS injection an aliquot of 0.2 μl urine was injected. In total, 96 peaks were detected, 
the highest being 1.35 x 104 AU (Fig. 3.8A).  However, after cEE-LC-MS, a larger aliquot 
of approximately 3 μl urine could be injected and the peaks were around 15 times higher 
(the highest being much higher; 25 x 104 AU) and as much as 136 peaks were found (Fig. 
3.8B), corresponding to an increase of 42% of the number of peaks. Probably, not all peaks 
represent peptides, but also a variety of endogenous metabolites. 
To emphasise the potential of cEE-LC-MS in the field of peptidomics, a brief feasibility 
study of the extraction of peptides from urine was carried out. To aliquots of 200 μL, 
different amounts of horse cytochrome C digestion were added, resulting, assuming complete 
digestion, in peptide concentrations of 10 μM to 0.2 μM. Angiotensin I (2 μM) served as 
internal standard. The most abundant tryptic peptide, TGPNLHGLFGR, m/z 1169.62, 
could be detected even at the lowest concentration of 0.2 μM (2.5 μg/L) with a signal-to-
noise ratio of ~50, corresponding to an LOD of this peptide around 0.015 μM. LOD values 
reported for LC-MS of peptides using similar columns and gradients, including evaporation 
of the SPE eluent, but larger injected sample aliquots, are between 0.065 and 1 μM [25]. 
The calibration curve (n = 3) showed excellent linearity (R2 > 0.99), good reproducibility 
(relative standard deviation 14 %) and a recovery (of the whole method, thus including RP-
SPE) of 56%. Moreover, several endogenous peptides were found, of which one could be 
identified to be bradykinin, which is a peptide known to occur in urine in a concentration 




In the cEE-LC-MS procedure used, an aliquot of approximately 3 μL urine is injected. 
Alternatively to cEE-LC-MS, the SPE-eluent (containing 70% ACN) can be injected 
directly. If the same urine aliquot as in the cEE-LC-MS experiments is then to be injected 
in a LC-MS system, 1 μL SPE eluent should be injected. An attempt to do this showed that 
this is not feasible (data not shown). This is because the elution strength of the SPE eluent 
(70% ACN) resulted in severely impaired separation on the used column (0.5 x 200 mm). 
It is possible to inject a higher volume of SPE eluent after it is sufficiently diluted with 
water, but this will not allow injecting an aliquot of 3 μL urine into this μLC system, where 
maximal 8 μL can be injected. One alternative would be evaporation of the eluent, but this 
results in the above mentioned disadvantages. Another alternative is to inject 3 μL untreated 
urine directly into the LC-MS system, but then high levels of contaminants are introduced 
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Figure 3.8 Extracted ion chromatograms of all peaks resulting from A) LC-MS with 1 μL injection, B) capillary 
cEE-LC-TOF-MS of urine spiked with cytochrome C digestion and internal standards after off-line SPE 1) 
cytochrome C peptide TGPNLHGLFGR, 2) angiotensin I. Other peaks are other cytochrome C fragments, 
putative endogenous peptides or other metabolites. Please note the difference of one order of magnitude between 





The process of EE has been characterised and it has been demonstrated that the developed 
EE protocol is applicable to systems with different physical dimensions. The potential of 
cEE of peptides has been demonstrated using a set of model peptides. The peptides were 
concentrated two orders of magnitude from the organic into the aqueous phase. Moreover, 
the on-line coupling of cEE with LC-MS via a valve interface allows concentration, separation 
and detection of the concentrated analyte plug and minimises sample handling after, e.g., an 
SPE step. Linear response of the on-line cEE-LC-MS set-up has been obtained for model 
peptides. The analysis of a protein digest showed no bias to pI value or hydrophobicity. 
Furthermore, cEE of peptides was applied to a biological matrix. cEE can serve as a simple 
and fast interface between SPE and LC. Instead of evaporation and reconstitution of an SPE 
eluent, it can be mixed with EtOAc and injected into the LC system. In combination with 
an SPE step good LOD values, comparable to current published LC-MS methods (at low 
nM level), could be obtained for endogenous peptides in urine,. On-line coupling of SPE to 
LC via cEE has our future attention, as has an improved design of the cEE set-up to increase 
the effective extraction volume and improving reproducibility. In addition, we will optimise 
the SPE step. By enhancing the loadability of the method, i.e. enlarging the extraction 
volume, lower LOD values can be reached. We aim at the analysis of an entire SPE eluent 
in one experiment. For improvement of reproducibility, it seems a logical step to ensure that 
the effective extraction volume equals the total present organic phase, since turbulence of the 
organic phase and diffusion do not affect the extraction result anymore. 
Next to peptides, metabolites have been detected in urine, suggesting that the EE 
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Abstract
In this research-paper we demonstrate a new electroextraction (EE) set-up and its on-line 
coupling with LC-MS. EE takes place in a two-phase liquid-liquid system, consisting of an 
aqueous and an organic phase, where an applied electric field causes ions to be extracted 
from one phase into the other, to be concentrated close after the liquid-liquid interface.
The extraction takes place in a wide-bore capillary that is connected to a 2-way 10-port 
switching valve, which serves to couple capillary EE (cEE) with LC-MS. In this set-up, 
volumes as high as 100 μL can be extracted, which is a ten times larger volume than has been 
reported, earlier, when cEE took place from a vial into a capillary. Moreover, it is faster. First, 
the feasibility of this set-up was studied using the cationic purple dye crystal violet. Then 
the method was coupled to LC-MS and large volume cEE of several model peptides was 
optimised. Both liquid phases, the extraction voltage and the extraction time were optimised 
and it was found that the addition of trifluoroacetic acid (TFA) improved extraction 
dramatically. Moreover, the presence of some ACN at the liquid-liquid interfaces improved 
cEE. The whole procedure was automated and could be used routinely. Calibration curves of 
5 test peptides in water have been constructed, resulting in good repeatability, good linearity 
and LOD values between 0.5 and 10 nM.
Finally, the method was applied to plasma analysis and calibration curves of the relevant 
plasma peptides angiotensin 1 and 2 as well as the 3-8 fragment of angiotensin 2 (angiotensin 
2 (3-8)) were constructed which had good linearity and repeatability; LOD values were 10-
50 nM. Analysis of unspiked plasma allowed the detection of about 60 putative endogenous 
peptides, underlining the great potential of EE as on-line sample concentrating technique. 
On-line large volume cEE-LC-MS allows for enrichment, separation and detection of 
plasma peptides from large sample volumes, minimises sample handling and can be an 
important step in full automation of analytical procedures.
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1. Introduction
The quickly erupting field of systems biology and metabolomics research is putting 
analytical methods for major challenges. In order to be able to characterise a biological 
system and come to a greater understanding of the system, data should be collected on as 
many relevant biological components as possible, preferably with one analytical method 
[1]. A complicating factor is the fact that many biologically relevant compounds occur at 
trace levels, as is for example the case for many peptides [2]. Therefore, to be able to acquire 
relevant metabolomics data, limits of detection (LOD) should be improved.
An option to improve the LOD is to use electroextraction (EE) in the sample pretreatment 
procedure. EE takes place in a two-phase liquid-liquid system, consisting of an aqueous and 
an organic phase, where, under the proper conditions, an applied electric field causes ions 
to be extracted from one phase into the other, to be concentrated just after the liquid-liquid 
interface [3]. At the start, the analyte ions are in the organic phase and since the conductivity 
of this phase is much lower than in the aqueous phase, a very high electric field strength 
exists there that causes these analytes to migrate very fast into the aqueous phase. Since the 
electric field strength that is present in the aqueous phase is very low, the analytes migrate 
with a very low speed. As a consequence, they are concentrated as they reach the aqueous 
phase. A crucial requirement of the organic phase is that it contains some water, in order to 
hydrate ions, enabling the presence of ions; for example ethyl acetate (EtOAc) can contain 
approximately 2.5% water and is therefore suitable for EE experiments. Initially, EE was 
developed to enhance product yields in industrial-scale solvent-solvent extractions [4-10]. 
In the 1990s, analytical EE was developed, coupled to CZE and LC and demonstrated with 
simple test solutions [11-13]. Recently, we reported capillary electroextraction (cEE) coupled 
to LC-MS to improve the LOD of peptides in complex samples [14]. Within 10 min, 
peptide peaks in the resulting chromatograms could be increased ~100 times by performing 
on-line cEE as sample preconcentration compared to a conventional sample injection of 0.1 
μL. However, we believed that the enrichment factor could be higher, without increasing the 
extraction time but rather decreasing it. 
The enrichment factor is mainly dependent on the volume of organic phase where an 
electric field is present. In the earlier cEE set-up, this volume was between the capillary 
inlet and the tip of the electrode, and was around 10 μL, the capillary tip being close to 
the bottom of the sample vial and the electrode tip being close the liquid surface [14]. This 
extraction volume was not fixed, but just a part of the total sample volume. On top of this, 
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the aqueous phase was in the capillary, above the organic phase, while the organic phase had 
a lower density. Dipping the capillary, with the plug close to its end, in and out vials during 
the measurement frequently resulted in sample plug loss, introducing unreliability in the 
cEE set-up. With an increased extraction volume, higher enrichment factors and therefore 
better LOD values should be achievable. In literature, modified electrode configurations to 
improve injection amounts in electrokinetic injection in CZE have been described [15, 16], 
but these solutions require complicated alterations of the CE apparatus and/or sample vials 
and increase the risk of sample carry-over. 
In the approach presented in this work, large volume cEE takes place in a wide-bore 
capillary (internal diameter of 1 mm). The liquid-liquid interface is located just in front of a 
valve with a sample loop. After cEE, the concentrated sample is pushed into a sample loop 
by shortly applying hydrodynamic pressure. The use of wide-bore capillaries in CE is not 
favourable due to extensive Joule heating, but in this case the large zone of low-conductive 
organic phase limits the current and as a consequence heat generation. Therefore, a high 
electric field strength could be applied. 
The large volume EE set-up was evaluated by performing experiments on solutions 
comprising several test peptides. The main system components were optimised, namely the 
composition of the organic and aqueous phases, the extraction voltage and the extraction 
time. It was found that adding a counter ion to the organic phase dramatically improved the 
EE of peptides. Acetic acid, formic acid (FA) and TFA were studied and it was found that 
TFA improved peptide extraction best. First, the composition of the aqueous and organic 
phase, the extraction time and the extraction voltage was optimised for several test peptides 
in water. Then the method was transferred to plasma analysis and successfully validated. 
2. Experimental
2.1 Chemicals
All reagents were of analytical grade or higher. A Millipore Q-guard water purifying 
system (Billerica, MA, USA) was used to obtain pure water. ACN, EtOAc, methanol, 
iso-propanol, dimethyl sulphoxide (DMSO), TFA and FA were obtained from Biosolve 
(Valkenswaard, The Netherlands), acetic acid from JT Baker (Philipsburg, NJ, USA) and the 
test peptides (bradykinin (1-5), mass 572; bradykinin (1-6), mass 660; ACIE-bradykinin, 
mass 964; bradykinin, mass 1060; angiotensin 2, mass 1296, angiotensin 1, mass 1046;  and 
substance P, mass 1347) from Genscript Corporation (Piscataway, NJ, USA). A protease 
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inhibitor cocktail (product number P8340) and crystal violet are from Sigma Aldrich (St. 
Louis, MO, USA).
2.2 Equipment and Techniques
2.2.1  Large volume cEE set-up
Voltage and pressure application during cEE experiments was achieved with an Agilent 
Technologies (Santa Clara, CA, USA) 1600 series CE apparatus, using LC Certified 
12x32mm screw thread autosampler vials with black 8 mm white silicone/red PTFE screw 
caps from Grace (Deerfield, IL, USA) and tubing and capillaries were purchased from 
Inacom Instruments (Overberg, the Netherlands). The 10-port 2-way switching valve with 
polyaryletherketone (PAEK) stator including actuator (Cheminert® HPLC injection valve 
model C2H-2340) was purchased at Valco Instruments (Houston, TX, USA). This valve is 
bio-compatible and the liquid has no contact with metal parts, preventing short circuiting 
and unsafe working conditions.  For injection of the aqueous and organic phases, the flush 
function of the CE apparatus was used. 
In Fig. 4.1 all the major components are depicted and in section 3.1 the procedure is 
described. During the whole procedure, the start signals of the CE apparatus is controlling 
the other components. 
 
2.2.2 Mass spectrometry
Mass spectrometric experiments were carried out on a Bruker Daltonics MicrOTOF 
mass spectrometer (Bruker Daltonics, Bremen, Germany). Spray settings were: end-plate 
offset -529 V, capillary voltage -2000 V, nebuliser gas pressure 0.4 bar, dry gas flow 4.0 L/
min and dry temperature 200 ˚C. Identification of the test peptides took place by searching 
for the known peptide masses.
2.2.3  Liquid Chromatography
LC was carried out with an Agilent Technologies 1200 series μHPLC apparatus, equipped 
with a ZORBAX SB-C18 (5 μm, 150 x 0.5 mm) capillary HPLC column, also purchased 
from Agilent. A 20 μL/min gradient elution was employed with 0.1 % FA in water as solvent 
A and 0.08% FA in ACN as solvent B, starting at 0% B and ending after 30 min at 35%. In 
plasma analysis, the gradient ended after 40 min. Post conditioning concerned 5 min 95% 
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2.3  Sample pretreatment
Plasma (EDTA, citrated, and heparin) was purchased from Richmond Pharmacology 
(London, Great-Britain. Ultracentrifugation took place in Microcon mass centrifugal filter 
devices (MW cut-off 30 kDa; Millipore, Billerica, MA, USA) using an Eppendorf 5415R 
centrifuge (Eppendorf AG, Hamburg, Germany) and for SPE an Oasis HLB μElution plate 
was used (30 μm, Waters Corporation, Milford, MI, USA). 
To break interactions between peptides and plasma proteins [17], plasma (300 μL) was 5 
times diluted with 5% DMSO. Then the sample was ultracentrifuged (mass cut-off 30 kDa, 
14000g, 4⁰C). After 50 min, 100 μL 5% DMSO was added and the sample was centrifuged 
for another 50 min. The filtrate was acidified with TFA (final concentration 1%), after 
which RP-SPE was carried out. The SPE material was wetted with ACN, equilibrated 
with 1% TFA, after which the sample was applied. Elution took place with 75 μL 100% 
ACN, which was directly mixed with 450 μL EtOAc for consecutive large volume cEE, by 
pipetting up and down. In one cEE experiment, 100 μL EtOAc is extracted, representing a 
plasma aliquot of 66.7 μL.
In the first instance, it was noticed that the peptide spikes, especially bradykinin, were 
degraded, resulting in unsatisfactory results. After adding a protease inhibitor mix (Sigma 
Aldrich, product number P8340 (St. Louis, MO, USA)), most of the degradation was 
avoided and results improved significantly.
3. Results and discussion
3.1 Description of the EE-LC-MS procedure
In Fig. 4.1, a scheme of the switching valve and the 4 main steps of the EE-LC-MS 
procedure are depicted. When the flush function of the CE apparatus is used, a pressure of 
approximately 950 mbar is applied on the inlet vial. This function was chosen to be able 
to quickly fill the large-volume EE capillary (part B in Fig. 4.1). The flow was restricted via 
the inlet capillary (part A in Fig. 4.1). The EE capillary, valve and outlet capillary had such 
a high inner diameter that virtual no back pressure was generated. By choosing optimal 
dimensions for the inlet capillary, a controlled flow was generated that allowed for precise 
injections within a reasonable time span. It was found that an inlet capillary with a length 
of 25 cm and an ID of 75 μm delivered just the right flow to obtain reasonable injection 
times (less than 3 min). To investigate whether this injection method was reliable, fixed-time
injections were carried out. The vials were weighed prior and after each injection period, to 
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be able to determine the injection volume. 
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Figure 4.1  Valve set-up for interfacing large volume cEE with LC. A) inlet capillary (fused silica, L 
= 25 cm, OD = 365 μm, ID = 75 μm), B) EE capillary (PEEK, L = 20 cm, OD = 1.59 mm,  ID = 1 
mm), C) sample loop (PEEK, L = 20 cm, OD = 1.59 mm, ID = 0.5 mm) D) outlet capillary (fused 
silica, L = 75 cm, OD = 365 μm, ID = 200 μm) E) LC waste (PEEK, L = 100 cm, OD = 1.59 mm, 
ID = 0.5 mm), F) LC pump tubing (PEEK, L = 30 cm, OD = 1.59 mm, ID = 50 μm), G) tubing to 
earth (PEEK, L = 20 cm, OD = 1.59 mm, ID = 0.5 mm). H) tubing to LC-MS (PEEK, L = 20 cm, 
OD = 1.59 mm, ID = 50 μm ) Step 1: situation after all phases have been loaded. The gray zone in the 
EE-capillary depicts the organic phase with analytes. Before EE starts, the valve is switched. Step 2: 
situation after EE is finished; the small black zone depicts the concentrated analytes. Step 3: situation 
after the sample has been transferred into the sample loop by applying pressure. After sample transfer, 
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influenced the injection volume; this is because temperature significantly influence the 
viscosity. This is undesirable, because when the location of the liquid-liquid interface is not 
well-controlled, the sample may not reach the sample loop completely or, on the other hand, 
be (partly) pushed beyond the loop. Therefore, the auto-sampler of the CE apparatus was 
cooled with streaming tap water, which controlled the temperature to 16.0-16.3 ⁰C. Then, 
the injection method appeared to be highly repeatable for both the organic (40.5 ± 0.23 μL/
min) and the aqueous phase (18.8 ± 0.054 μL/min). In summary, the location of the liquid-
liquid interface and therefore also the injection volume could be controlled very accurately. 
During step 1 of the cEE-LC-MS procedure (Fig. 4.1), the EE capillary (B) was filled with the 
aqueous and organic phases via the inlet capillary (A). First, 0.1% FA in water was injected, 
which was the mobile phase used in LC. Then, EtOAc, containing the analytes, was injected 
and finally the second aqueous phase, containing 5% FA. Optimisation of the composition 
of the liquid phases will be discussed in section 3.3.2.1 and 3.3.2.2. After the loading step was 
finished, the valve was switched and cEE started (step 2). During cEE, the electrical circuit 
was grounded via an external vial containing 0.1% FA. As soon as the positive voltage was 
applied, the cationic analytes migrating towards the ground electrode (earth) were extracted 
and concentrated into a small zone. At the beginning of each measurement day, the tubing 
to earth (part G in Fig. 4.1) was flushed with 0.1 % FA to ensure good connection with 
earth. When cEE was finished, the sample zone was transferred into the sample loop using 
hydrodynamic pressure (step 3) after which the valve was switched back and the sample was 
injected in the LC-MS system and consecutive LC-MS analysis took place (step 4). The 
whole large volume cEE-LC-MS procedure was automated and was able to run without 
human interference for at least 18 hours, performing 24 experiments in a row.
The location of the liquid-liquid interface in the system is of crucial importance for the 
success of the experiments. In the first instance, it was attempted to carry out cEE in the 
port-to-port volume (internal loop volume) of the valve. However, this appeared to result in 
current leakage through the valve, due to the very low conductivity of the large EtOAc zone. 
Therefore, ideally, the interface is just in front of the valve. Then, after cEE, only a short 
pressure application step is needed to push the sample into the sample loop. 
At first, a series of feasibility experiments was carried out in which 0.5 μM crystal violet 
was extracted from EtOAc into 0.1 % FA in a transparent EE capillary (PTFE, 20 cm x 
0.8 mm) to be able to visually follow the progress of cEE (Fig. 4.2). On top of this, the 
current behaviour during cEE was monitored. The purpose of these experiments was to 
globally characterise how the liquid-liquid interface behaved and to study the cEE process 
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at different electric field strengths.
It was observed that when a voltage higher than 1 kV was immediately applied, the 
cEE process was halted due to bubble formation. When the voltage was kept at 1 kV or 
lower during the whole experiment, extraction times became unfavourably long (> 10 min). 
However, it was found that when the voltage was increased gradually after applying a start 
voltage of 1kV no bubble formation occurred and complete extraction could be achieved 
within a minute. As shown in [14], the current is maximal at the start of cEE, after which 
it decreases exponentially. When the extraction voltage is low at the start of cEE, excessive 
Joule heating which results in bubble formation can be avoided.
t = 0 s t = 19 s t = 38 s
interface
interface
anode side / to switching valve




Figure 4.2 Video stills of cEE of the purple dye crystal violet in a 0.8 mm ID PTFE capillary. The organic phase 
consisted of EtOAc containing 0.5 μM crystal violet; the aqueous phase at the anode side of 0.1% FA and the 
aqueous phase at the cathode side of 5% FA.
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It was also observed that during the loading procedure water droplets sometimes occurred 
in the organic phase. Despite the fact that these artefacts in the organic phase did not 
prevent cEE from taking place, it took longer and the current profile became unpredictable. 
However, it was found that when some ACN, which is miscible with both water and 
EtOAc, was injected before and after the organic phase, no water droplets occurred and 
cEE performance was significantly improved. The effect of injecting similar amounts of 
methanol, ethanol and isopropanol at the liquid-liquid interfaces were studied as well and 
showed similar effects. The volume of ACN that was injected was varied as well. When 1 
μL ACN was used, cEE stability and speed was observed to be optimal (data not shown). 
Apparently, the presence of a small quantity of polar organic solvent at the interface that is 
soluble in both liquid phases is beneficial for cEE. The explanation for these observations is 
a subject for ongoing research. 
It was also observed that increasing the FA concentration of the aqueous phase increased 
the extraction speed dramatically. This can be explained by the larger electric field strength 
that will be in the organic phase when the conductivity of the aqueous phase increases.
3.2 Application to peptides
3.2.1 System alterations
After the feasibility experiments, the method was coupled to LC-MS and the extraction 
of 5 test peptides was optimised. In these experiments, a PEEK capillary (20 cm x 1 mm 
ID) was used instead of the 20 cm x 0.8 mm ID PTFE capillary mentioned in the previous 
section, to increase the extraction volume. PTFE tubing of 1 mm ID appeared to be too 
difficult to connect properly due to the softness of the material; therefore a PEEK capillary 
was used. The organic sample volume was 100 μL for this set-up. Chromatographic peak area 
was used as measure for the extraction efficiency. The loading procedure in all experiments 
was as follows: 1) 10 min 950 mbar with 0.1% FA 2) 24 s 50 mbar ACN 3) 2.66 min 950 
mbar EtOAc with analytes (= 100 μL) 4) 24 s 50 mbar ACN 5) 3.2 min 950 mbar with 
5% FA. Then, the cEE process was started. After cEE was finished, the generated sample 
plug was pushed into the injection loop with 0.95 min 950 mbar, after which the valve was 
switched and the sample was injected into the LC-MS system. The resulting chromatograms 
showed good separation, an example of which can be seen in Fig. 4.4.
3.2.2 Organic phase optimisation
When only test peptides were present in the EtOAc, almost no current was observed 
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and the resulting chromatogram contained only low peptide peaks. This is not surprising, 
since there is a zone with very low conductivity with a length of 12.7 cm present that acts 
as insulator. To improve extraction, the conductivity of the EtOAc zone was increased. The 
addition of a small amount of pure FA (pKa 3.77), acetic acid (pKa 4.76) or TFA (pKa 0.23) 
was investigated. First, a series of experiments (n=3, EE time 4 min, EE voltage gradient 
1 to 15 kV) was carried out with 0.1% or 1% of one of the three acids present in the 
organic phase. From these experiments it became clear that, while all three acids caused an 
increased, comparable current, TFA enhanced the peptide extraction by far the best (Fig. 
4.3A). Moreover, 1% acid had a greater effect than 0.1% in the case of all three studied 
acids. TFA is the strongest acid of the three acids studied and an acidic environment is 
obviously favourable for peptides to be present in the cationic form. However, more research 
will be required to assign the effects of adding acids.  
Next, the TFA concentration was optimised. A series of experiments (n = 3, equal EE 
conditions) was carried out in which the amount of TFA was varied (0.2% to 1.8% in steps 
of 0.2%). The results of these experiments indicated that the TFA concentration was not 
of great influence on the peak area (data not shown). At the highest TFA concentration the 
peptide peak areas were slightly larger, while the overall relative standard deviation improved 
also slightly. When TFA concentrations above 1.8% were used, the current became so high 
that too much Joule heating took place leading to bubble formation and consequently 
decreased cEE performance or even failure of experiments. In the rest of the experiments, 
1.8% TFA was present in the organic phase. 
3.2.3  Aqueous phase optimisation
The aqueous phase into which the peptides were extracted had to be injected into the 
LC. To avoid sample solvent related problems during LC separation, this aqueous phase was 
chosen to be mobile phase A, i.e. 0.1% FA, and not further optimised.
The composition of the aqueous phase at the other side of the organic phase, however, 
was optimised. In cEE experiments with crystal violet, it was noticed that when a higher FA 
concentration was used, cEE proceeded faster (see section 3.1). Since the conductivity of 
the aqueous phase increases at increased FA percentage, the electric field strength decreases. 
This causes a higher electric field strength in the organic phase and therefore faster ion 
migration in the organic phase. In a series of experiments (n = 3, EE time 4 min, EE voltage 
15 kV, 1.8% TFA in organic phase), the FA concentration was varied and the relative peak 
area increased from 0.1% to 2% FA after which it remained rather constant with a slight 
optimum at 5% FA (Fig. 4.3B).
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3.2.4 Extraction voltage and time optimisation
During several series of experiments, all carried out in triplicate, the optimal HV and 
extraction time were determined (other conditions: 1.8% TFA in organic phase, 5% FA the 
aqueous phase at the inlet side, 0.1 % FA at the outlet side). It was studied how fast the HV 
could be increased and how long it should be applied after it reached its maximum. As can 
be seen in Fig. 4.3C, the optimal HV appeared to be 25 kV. The optimal time to increase the 
HV from 0 to 25 kV was 4 min, i.e. 6.25 kV/min. When faster HV gradients were applied, 
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Figure 4.3 A) influence of presence of two concentration levels of acetic acid (AA), FA (FA) and TFA (TFA) 
on the extraction of 5 test peptides from EtOAc, B) optimisation of FA in aqueous phase C) optimisation of 
extraction voltage D) optimisation of extraction time. Relative peak area is calculated by setting the highest 
obtained value at 100%.
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maximal HV of 25 kV was reached, prolonging the extraction time did not increase peptide 
extraction (Fig. 4.3D). All peptides showed the same pattern in these voltage and time 
optimisation series of experiments, indicating that differences in electrophoretic mobility 
have no influence on the extraction success at this timescale.
In summary, the optimal cEE voltage procedure was to start at 0 kV and increase with 
6.25 kV/min to the maximum voltage, being 25 kV. 
3.2.5  Enrichment effect
To determine the enrichment factor that the optimised cEE procedure can achieve, 
chromatographic peak areas resulting from large volume cEE-LC-MS were compared with 
conventional 0.1 μL LC-MS injections (the maximal injection volume advised by the column 
manufacturer when the sample is not in water) of the sample. The starting concentration of 
the peptides was equal in cEE-LC-MS and LC-MS experiments. In Fig. 4.4, a comparison 
between a conventional LC-MS injection of 0.1 μL EtOAc and a cEE-LC-MS injection of 
100 μL EtOAc containing peptides is shown. Based on this comparison, enrichment factors 
could be determined to be 570 times for thymopentin, 840 times for bradykinin (1-6), 990 
times for bradykinin (1-5), 830 times for ACIE and 590 times for angiotensin 2 (3-8). 
This is a significant improvement with respect to the previously described cEE method, 
where enrichment factors of ~100 were obtained [14]. Whereas the maximum possible 
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Figure 4.4 Comparison of chromatograms obtained from LC and large volume cEE-LC-MS analysis. After 
an EE step of only 4 min, peaks are considerably higher. Injection volume in LC was 0.1 μL EtOAc; extracted 
organic phase in EE was 100 μL. The initial peptide concentration was equal.
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optimisation, it was shown that prolonging the extraction time does not result in increased 
peptide peak areas (Fig. 4.3D). A possible explanation for the sub-maximal enrichment 
factors is peptide loss due to wall adsorption, a phenomenon that has been reported 
previously in literature [18, 19]. 
3.2.6 Linearity and repeatability
When constructing calibration curves, it was noticed that at low analyte concentrations, 
the peak area of the internal standard (bradykinin) decreased, even though the concentration 
of it was equal in all calibration samples. This affected the linearity of the calibration curves 
(data not shown). As mentioned in section 3.3.2.4, a probable reason is adsorption of the 
peptides to the wall. As a remedy, 2 μM substance P was added to all samples to suppress 
analyte and internal standard adsorption by competition. This resulted in equal internal 
standard peak areas in all calibration measurements. Satisfactory calibration curves (range 
0.2 - 1000 nM in water) of the 5 test peptides could be constructed (n=3), of which the 
regression data is shown in Table 4.1. Regression analysis showed that the curves had no 
significant intercept with the y-axis (P < 0.05 at a confidence level of 95%), which indicated 
that the lines could be drawn through origin. The repeatability and linearity were good and 
LOD values were between 0.5 and 10 nM
3.3  Application to plasma analysis
3.3.1 Sample pretreatment prior to plasma analysis
When untreated, i.e. when no SPE or ultrafiltration was applied and plasma was directly 
mixed with EtOAc prior to cEE, low peptide recovery was obtained and the EE process was 
unreliable. Therefore, plasma samples were deproteinated with ultrafiltration and desalted 
with RP-SPE. The trapped peptides were eluted from the cartridge with ACN. Instead 
of evaporating the SPE eluent and reconstitution in water before injection into the RP-







thymopentin 0.56 ± 0.072 0.034 18 0.985 0.01-1
bradykinin 1-6 0.43 ± 0.022 0.0094 21 0.998 0.005-1
bradykinin 1-5 0.77 ± 0.041 0.017 21 0.997 0.005-1
ACIE 1.22 ± 0.067 0.025 30 0.997 0.0005-1







Table 4.1 Analytical performance characteristics of cEE-LC-MS analysis of test solutions of model peptides
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LC system, which is common practice in peptide analysis [20, 21], the eluent was mixed 
with EtOAc by pipetting up and down and cEE was performed. This required less sample 
handling; therefore it is less labour-intensive, less susceptible to experimental errors and 
easier to automate. Test runs with EDTA, heparinated and citrated plasma showed similar 
results and EDTA plasma was chosen for all further experiments. 
3.3.2 Quantitative aspects
Contrary to test mixtures, a multitude of charged compounds can be expected to be 
present in plasma analysis, even after desalting. This will likely influence the EE process and 
therefore, cEE voltage and time were re-optimised. It was found that above 15 kV, the liquid-
liquid interface became instable and that when 15 kV was used as maximal voltage, the 
extraction time had to be prolonged with 2 min (data not shown). In summary, the voltage 
was increased in 4 min from 0 to 15 kV (3.75 kV/min) and then 15 kV was maintained 
for 2 more min. Under these circumstances, similar enrichment factors (500-1000 times) as 
with the academical mixtures were achieved (data not shown).
The recovery of the ultrafiltration and SPE procedure was studied. Large volume cEE-
LC-MS peak areas resulting from samples spiked prior to and after ultrafiltration and SPE 
were compared. The recoveries were determined to be 87 ± 2% for angiotensin 2 (3-8), 82 
± 17% for angiotensin 1, 70 ± 10% for bradykinin, 62 ± 11% for angiotensin 2, and lower 
than 5% for thymopentin, bradykinin (1-5) and bradykinin (1-6) (n=3).  The low recoveries 
obtained for both thymopentin, bradykinin (1-5) and bradykinin (1-6) fragments are not 
caused by cEE (as shown in section 3.3.2.4, large volume cEE of these peptides is highly 
feasible) but can be explained by the fact that the SPE conditions were not optimal for these 
rather hydrophilic peptides. 
Then, calibration curves of the relevant plasma peptides angiotensin 1 and 2 as well 
as angiotensin 2 (3-8) spiked to plasma were constructed, using bradykinin as internal 
standard, and measured in triplicate (Fig. 4.5). Regression analysis showed that the curves 
had no significant intercept with the y-axis (P < 0.05 at a confidence level of 95%), which 
indicated that the lines could be drawn through origin. Linearity was good to excellent, R2 
0.990 - 0.998, and mean relative standard deviation of the slope satisfactory between 1 % 
and 18%. LOD values were 10-50 nM (Table 4.2). 
Large volume cEE-LC-MS experiments performed on unspiked plasma resulted in 
around 60 putative endogenous peptides (Fig. 4.6).
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range (uM) LOD 
(nM)
angiotensin 2 6.36 ± 0.086 0.31 18 0.991 0.005-1 10
angiotension 2 (3-8) 0.18 ± 0.00054 0.03 18 0.994 0.05-5 50
angiotensin 1 0.76 ± 0.10 0.23 18 0.984 0.05-5 50
Table 4.2 Analytical performance characteristics of large volume cEE-LC-MS of three peptides spiked 
to plasma
Figure 4.5 Calibration curves and data of angiotensin 1, angiotensin 2 and angiotensin 2 (3-8) in plasma (n = 3).
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4. Conclusions
We described the set up, optimisation and biological application of large volume cEE-
LC-MS of peptides. The method presented in this chapter is capable of on-line enrichment 
of peptides within 4 min, resulting in significantly increased peak heights compared to 
conventional LC injection. Enrichment factors were between 570 and 990 times when 
compared with a conventional LC injection. In comparison with the previously described 
cEE set-up [14], the method is capable of extracting larger volumes, resulting in significantly 
higher enrichment factors, and it is faster. The addition of TFA improved EE dramatically. 
The whole procedure has been automated and could be used routinely for plasma. Linearity 
and repeatability were excellent between 0.2 nM and 1000 nM. The described method is fully 
automated and minimises sample handling after SPE (i.e. evaporation and reconstitution 
steps). Therefore, it can be an important step in full automation of analytical procedures. 
Future research will be devoted to coupling of SPE directly to large volume cEE, to coupling 
of large volume cEE to other separation methods than RP-HPLC and to analysis of other 
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Abstract
In this work we demonstrate the applicability of electroextraction (EE) to urine 
metabolites. To investigate which urine metabolite classes are susceptible to EE, off-line 
EE experiments were carried out with a prototype device, in which urine metabolites were 
electroextracted from ethyl acetate (EtOAc) into water. The obtained extracts were examined 
with direct infusion MS and the results demonstrated that several compound classes could 
be extracted, amongst which amino acids and acylcarnitines. Acylcarnitines were selected 
for evaluation of the performance of EE. For this, the EE set-up was adapted to capillary 
EE (cEE) to be able to analyze large urine sample series, and it was coupled on-line to LC-
MS. cEE-LC-MS of acylcarnitines was optimised and characterised. The recovery, linearity, 
repeatability and limit of detection of the cEE-LC-MS method was good to excellent. To 
demonstrate the versatility of EE for sample preparation in analytical procedures, extracts 
were injected into a CZE-MS system, resulting in detection of the acylcarnitines along with 
more than 100 presumed metabolite peaks. The results presented here indicate that EE can 
be used as a fast sample preconcentration technique of low abundant urine metabolites, in 
combination with both LC and CZE.  
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1. Introduction
Metabolomics studies typically involve the measurement of large sample sets. To be able 
to gain more insight into important metabolic processes, as many metabolites as possible 
should be measured, including the low-abundant ones that often are of high biological 
relevance. Therefore, fast analytical techniques are required that are capable of measuring 
many low-abundant compounds.
Sample pretreatment procedures that are based on electromigration are very promising, 
because they meet the requirements mentioned above in several ways. First, a considerable 
part of the metabolome consists of compounds that are or can be charged and so are suitable 
for an electrophoretic approach, such as fatty acids, carbohydrates, nucleotides, amino 
acids and acylcarnitines [1]. Furthermore, electromigration can be used to concentrate 
analytes. Despite the fact that this approach is well-known in CE-based techniques [2-4], 
relatively few examples of the application of electromigration-based sample pretreatment 
to large sample volumes can be found in literature. One example is electrodialysis, which 
has been applied as a fast and selective sample pretreatment method to LC-MS analysis 
of low-abundant peptides in synovial fluid [5]. Other examples of electromigration-based 
sample pretreatment techniques that have been applied to complex samples are preparative 
isotachophoresis [6-8] and isoelectric focusing [8]. 
Another electromigration-based analyte preconcentration technique is electroextraction 
(EE), which is capable of concentrating analytes two-three orders of magnitude within 
several minutes, resulting in improved LOD [9, 10]. EE takes place when an electric field is 
applied to a two-phase liquid-liquid system consisting of an aqueous and an organic phase. 
Ions in the organic phase are subjected to a very high electric field strength, due to the very 
low conductivity. As a consequence, they migrate at full speed towards the liquid-liquid 
interface, to be concentrated in the aqueous phase directly after they pass the interface, 
because the electric field strength is so much lower there [9, 10]. Initially, EE has been 
developed as a purification technique in the field of chemical engineering, to enhance product 
yields resulting from solvent extraction [11-16]. However, EE can also be used to enhance 
the sample aliquot that is injected into analytical methods. In the 1990s Van der Vlis et al. 
adapted EE for analytical purposes, using EtOAc as organic phase and performing EE of test 
solutions in capillaries (cEE) [17-19]. Recently, we showed the successful application of cEE 
coupled to LC-MS to the analysis of peptides in urine [9]. Then, we further improved cEE 
to large volume cEE and showed extraction of plasma peptides from large sample volumes 
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(up to 100 μL) coupled to LC-MS [10].
So far, cEE has been reported for some β-agonists, leukotrienes and catecholamines from 
test mixtures [17-19] as well as cEE of peptides in urine and plasma [9, 10]. The goal of this 
research paper is to demonstrate that cEE is applicable to a wider range of compound classes 
in complex samples than has been demonstrated so far. Therefore, the performance of EE as 
sample pretreatment of human urine samples was investigated. In a quantitative screening 
experiment using a prototype EE device (Fig. 5.1), it was investigated which metabolite 
classes are susceptible to EE. Due to its biological relevance [20], in further experiments 
the focus was put on analysis of acylcarnitines. The performance of EE of acylcarnitines in 
urine was evaluated with consecutive on-line LC-MS analysis. On-line large volume cEE as 
described in [10] was optimised, then calibration curves of 4 acylcarnitines spiked to urine 
were generated and endogenous levels were determined by the standard addition method. 
Finally, to assess how versatile EE is as a generic sample pretreatment technique, EE was 
coupled off-line to CZE-MS instead of LC-MS.
2. Experimental
2.1 Chemicals
All reagents were of analytical grade or higher. A Millipore Q-guard water purifying 
system (Billerica, MA, USA) was used to obtain pure water. Acetonitrile (ACN), EtOAc, 
formic acid (FA), ammonium hydroxide, sodium hydroxide and TFA were obtained from 
Biosolve (Valkenswaard, The Netherlands). The acyl-L-carnitine standards were from Sigma 
(St. Louis, MO, USA). 
2.2  Sample pretreatment
L-acylcarnitine stock solutions of 5 mM were prepared in 1:1 water/methanol (v/v), and 
were stored at -20° C. Stock solutions of 0.5 mM and 0.05 mM were made by dilution with 
1:1 water/methanol (v/v). Calibration solutions were made by adding various amounts of 
the stock solutions to water or urine. Urine was collected from 3 healthy volunteers, pooled, 
centrifuged and stored at -80° C in aliquots of 1 mL. This urine was used in all experiments.
2.3 Equipment and techniques
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2.3.1  Screening experiment with off-line EE set-up
The prototype EE device (Fig. 5.1) has been described in detail in [9]. In short, the 
device consisted of a polychlorotrifluorethylene (KelF) vial with a pointed bottom, where 
a capillary and a platinum grounding electrode were located. The capillary served to inject 
and remove aqueous phase underneath the organic phase, in the pointed bottom of the 
device. The electric circuit was closed by using a piston-like gold coated electrode as anode 
fitting exactly in the vial, thus contacting exactly the whole surface of the organic phase to 
ensure that all charged molecules in the organic phase were in the electric field. High voltage 
(HV) was applied with a Spellman HV Power Supply (Spellman, Hauppauge, New York, 
USA). Urine was brought to 2% FA and 20 μL was added to 10 mL EtOAc. The sample was 
centrifuged 5 min at 15000 g to remove insoluble particles, after which EE was performed 
on the supernatant at 2.5 kV for 10 min, with 150 μL 0.1% FA as aqueous acceptor phase. 
adjustable anode
organic phase
(10 mL EtOAc with 
  sample)
aqueous phase




Figure 5.1 Schematic drawing of the off-line EE prototype device  
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The extracts were infused into a linear triple quad - ion cyclotron resonance - Fourier 
transform - mass spectrometer (LTQ-FTICR-MS) (Thermo Fisher Scientific, San Jose, 
CA, USA) to obtain accurate mass values of the extracted compounds. Direct infusion 
mass spectra were measured, at a resolution of 100000. To get an impression of which 
metabolite classes were extracted, the most intense recorded masses (mass range 50-300 m/z) 
were matched with a database (www.hmdb.ca, [1]), taking 0.06 Dalton as maximal mass 
difference for identification.
2.3.2  On-line large volume cEE-LC-MS set-up
The on-line large volume cEE-LC-MS set-up (Fig. 5.2) has been described in detail 
recently [10]. In short, aqueous and organic phases were injected into a capillary (part B in 
Fig. 5.2) and the location of the interface was chosen to be just in front of the valve (step 1). 
Then, the valve was switched and the extraction voltage was applied. When cEE is finished 
(step 2), the concentrated sample plug was transferred into the sample loop (step 3) by 
applying pressure, after which the valve was switched back to inject the sample into the LC-
MS system (step 4). Voltage and pressure application during cEE experiments were done 
with an Agilent Technologies (Santa Clara, CA, USA) 1600 series CE apparatus. The start 
signal of the CE apparatus was used as a trigger pulse for the valve, LC and MS. 
LC was carried out with an Agilent Technologies 1200 series μHPLC apparatus, 
equipped with a ZORBAX SB-C18 capillary HPLC column (5 μm, 150 x 0.5 mm; Agilent 
Technologies). A 20 μL/min gradient elution was employed with 0.1 % FA in water as 
solvent A and 0.1% FA in ACN as solvent B and consisted of 5 steps: 1) 1 min 100% A, 2) 
decrease to 20% in 14 min 3) 6 min at 20% A, 4) 5 min at 0% A for cleaning and 5) 5 min 
at 100% A for reconditioning. On each measurement day, a blank run was performed first.
Detection was achieved with a Bruker Daltonics MicrOTOF mass spectrometer (Bruker 
Daltonics, Bremen, Germany). Mass spectra from the time-of-flight MS (TOF-MS) were 
internally calibrated using a sodium formate adduct plug (10 mM NaOH, 0.1 FA in 1:1 
methanol/water) that was infused (using a Pharmacia LKB HPLC Pump 250 (Uppsala, 
Sweden)) at the end of every chromatogram via the switching valve on the MS. 
2.3.3 CZE-MS
Experimental conditions of CZE experiments were based on [21] and were carried out 
using an Agilent Technologies 1600 series CE apparatus. An untreated fused capillary was 
used (length 80 cm, ID 75 μm) and hydrodynamic injection was employed (2s, 50 mbar). 
Separation took place in 0.8% FA as background electrolyte under a separation voltage of 30 
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 kV.  Between measurements, the capillary was reconditioned by flushing 5 min with distilled 
water, 5 min with 1 M ammonium hydroxide and 5 min with background electrolyte. The 
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Figure 5.2  Valve set-up for interfacing large volume cEE with LC. A) inlet capillary (fused silica, L = 25 cm, 
OD = 365 μm, ID = 75 μm), B) EE capillary (PEEK, L = 20 cm, OD = 1.59 mm,  ID = 1 mm), C) sample loop 
(PEEK, L = 20 cm, OD = 1.59 mm, ID = 0.5 mm) D) outlet capillary (fused silica, L = 75 cm, OD = 365 μm, 
ID = 200 μm) E) LC waste (PEEK, L = 100 cm, OD = 1.59 mm, ID = 0.5 mm), F) LC pump tubing (PEEK, L 
= 30 cm, OD = 1.59 mm, ID = 50 μm), G) tubing to earth (PEEK, L = 20 cm, OD = 1.59 mm, ID = 0.5 mm). 
H) tubing to LC-MS (PEEK, L = 20 cm, OD = 1.59 mm, ID = 50 μm ) Step 1: situation after all phases have 
been loaded. The gray zone in the EE-capillary depicts the organic phase with analytes. Before EE starts, the valve 
is switched. Step 2: situation after EE is finished; the small black zone depicts the concentrated analytes. Step 3: 
situation after the sample has been transferred into the sample loop by applying pressure. After sample transfer, 
the valve is switched back. Step 4: situation where the sample zone is being injected into the LC-MS system.
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sheath-liquid assisted sprayer which was also from Agilent Technologies (part number 
1607-60001). The sheath liquid consisted of 50/50% methanol/ 0.1% acetic acid in distilled 
water and was delivered with an Agilent Technologies 1100 series pump at a rate of 10 μL/
min. 
3. Results and discussion
3.1 Off-line EE
The purpose of this screening experiment was to quickly get a rough idea which metabolite 
classes in urine are susceptible to EE. For this, electroextracts from urine were infused into 
an LTQ-FTICR-MS for accurate mass determination and, using the human metabolome 
database, 49 masses could be putatively attributed to metabolites that were electroextracted 
into the aqueous phase. The number of putatively identified metabolites can be expected 
to be higher, since the mass spectra contained hundreds of peaks. However, the purpose of 
this experiment was, as mentioned above, to obtain a rough impression of which metabolite 
classes can be electroextracted from urine. Therefore, no further effort was made to annotate 
all the mass peaks. Definitive identification of the metabolites requires MS/MS of MSn 
analysis of the observed masses, which is beyond the scope of this study.
Many of the supposed identified metabolites were amino acids and acylcarnitines (Table 
5.1). To optimise the cEE procedure, to validate with cEE-LC-MS and to demonstrate the 
potential of the cEE approach, acylcarnitines were chosen as metabolite class of interest. 
Acylcarnitines (carnitine esters) are conjugates of carnitine and fatty acids that can function 
as biomarkers for various inborn metabolism errors; many genetic and acquired disorders 
affect the acylcarnitine levels in biological fluids [20].
The prototype device is useful for a quick experiment, but for the analysis of a large series 
of samples, the set-up of the method has to be automated and coupled on-line. Therefore, 
an on-line large volume cEE set-up was optimised for acylcarnitines and coupled to LC-MS.
3.2 On-line large volume cEE of acylcarnitines in urine
The cEE-LC-MS set-up that has proven its potential for peptides [10] was now optimised 
for acylcarnitines. In a series of experiments, the extraction voltage and TFA concentration 
(0, 0.1, 0.5, 1, 1.5 and 2%) were optimised using test solutions of EtOAc that was saturated 
with acylcarnitines in water. The injected volume of organic phase extracted was 100 μL. 
The extraction procedure was as follows: in 4 min the voltage was gradually increased from 
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1 kV to the maximum voltage (1, 15 or 30 kV), after which the maximum voltage was 
maintained for 2 additional min. As can be seen in Fig. 5.3A, 15 kV was sufficient and it 
was therefore selected for subsequent experiments. 
    
Apart from a blank, 5 different TFA concentrations were studied (Fig. 5.3B). In [10], 
it was found that the addition of TFA to the organic phase improved cEE of peptides 
dramatically. Between 0.1% and 2% TFA, the results were satisfactory for all acylcarnitines, 
except for stearoylcarnitine. The unpredictable results of stearoylcarnitine are possibly due to 
its low solubility in water. However, when no TFA was added, peak areas were significantly 
lower and not reproducible. There were no marked differences between 0.5%, 1% and 1.5% 
TFA. The lowest suitable concentration, 0.5% TFA, was chosen for the remainder of the 
experiments to avoid risk of excessive Joule heating caused by the increased conductivity. As 
the results obtained for HV and TFA optimisation were very similar to the results obtained 
in peptide analysis [10], the same extraction time and aqueous phase composition were 
selected. 
Summarising, the final cEE procedure was a HV gradient of 4 min from 1 to 15 kV, 





















Table 5.1 List of classes of putatively assigned compounds 
detected in urine by off-line EE/DI-LTQ-FT-MS compounds 
classes and detected number of compounds per class
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followed by 2 more min of 15 kV. The TFA concentration was 0.5%, the aqueous phase at 
the cathode side 5% FA and at the anodic side 0.1% FA (i.e. the LC mobile phase). 
  
Peak areas of chromatograms resulting from on-line large volume cEE-LC-MS (100 
μL) and LC-MS (0.1 μL) of EtOAc saturated with acidified urine were compared (Fig. 
5.4) and it was found that the peak area of hexanoylcarnitine was increased 970 times, 
decanoylcarnitine 920 times, octanoylcarnitine 790 times, stearoylcarnitine 640 times and 
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A) influence of extraction voltage
B) influence of TFA
Figure 5.3 Optimisation of A) extraction voltage and B) TFA concentration. 
Relative peak area was calculated per acylcarnitine, by setting the highest obtained 
peak area per acylcarnitine to 100%
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amount to maximally 1000 times, which demonstrates that the cEE of hexanoylcarnitine 
and decanoylcarnitine is virtually complete, while some loss of octanoylcarnitine and 
stearoylcarnitine occurs. The low recovery of acetylcarnitine might be explained by the fact 
that it elutes from LC with the void volume in 100 % solvent A (0.1% FA), which makes 
it difficult to compare the conventional LC injection with the cEE-LC injection, due to 
possible ion suppression by matrix compounds. 
 
   
After optimisation experiments with acylcarnitine test solutions, acylcarnitines spiked 
to urine were analyzed. In one single run, an aliquot of 2 μL urine was analyzed, i.e. 100 
μL EtOAc saturated with urine was electroextracted. Sample pretreatment of the urine only 
required acidification with TFA, mixing with EtOAc and centrifugation prior to transfer into 
an autosampler vial for subsequent cEE-LC-MS analysis. In Fig. 5.5, the calibration curves 
obtained for acetylcarnitine, hexanoylcarnitine, decanoylcarnitine and stearoylcarnitine 
spiked to urine are shown. For the calibration curve of acetylcarnitine, a separate series 
of measurements was carried out, because its high endogenous concentration required a 
different calibration range and internal standard concentration. Octanoylcarnitine was 
used as internal standard (20 μM in the case of acetylcarnitine, 2 μM in the remainder). 



























Figure 5.4 Comparison of chromatograms obtained from LC and cEE-LC-MS analysis of acylcarnitines 
spiked to urine. After a cEE step of only 6 min, peaks are considerably higher. Injection volume in LC was 
0.1 μL; extracted organic phase in cEE was 100 μL. The initial acylcarnitine concentration in urine was equal 
(octanoylcarnitine 20 μM, other acylcarnitines 50 μM). 
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μM in the case of acetylcarnitine and 0, 0.05, 0.1, 0.2, 0.5, 1, 2, and 5 μM in the other 
acylcarnitines. 
Repeatability (characterised by the analysis of three calibration sample sets) and linearity 
are excellent in the whole range (n = 3). In the blank urine samples, acetylcarnitine, 
hexanoylcarnitine and stearoylcarnitine peaks were detected (Fig. 5.6). The signal-to-noise 
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ratio of the endogenous peaks was 25-112, which was sufficient for quantification, and the 
endogenous concentrations that were found are given in Table 5.2. Based on the signal-to noise 
ratios of the endogenous peaks, the LOD could be estimated to be 0.18 μM for acetylcarnitine, 
0.008 μM for hexanoylcarnitine and 0.007 μM for stearoylcarnitine, corresponding to on-
column injected amounts of 1 around pmol, 50 amol and 20 amol (based on the injection 
volume of 2 μL). In the case of hexanoylcarnitine and stearoylcarnitine, these values are 
roughly one order of magnitude more favourable than methods described in the literature 
[21, 22], describing sample pretreatment involving multiple steps. In [23], acylcarnitines 
were also observed in urine with LC-MS. When taking into account the different column 
dimensions (2 mm in [23], 0.5 mm here), the injected aliquot of urine is increased 16 times. 
An advantage of on-line large volume cEE is the minimal sample handling; after having 
mixed the urine with EtOAc, centrifugation and transferred it to an autosampler, the whole 
analysis takes place without further human interference. In consequence, the method is 
not labour-intensive and no errors and sample losses inevitably associated with each extra 
sample handling, such as evaporation and reconstitution [21, 22], are introduced. For 
example, in [22], urine was first diluted 5 times with water, then acidified with HCl (1 M) 
and finally subjected to strong cation exchange SPE. The eluent was evaporated to dryness, 
reconstituted in 1 mL methanol, re-evaporated and then reconstituted in methanol-water, 
prior to injection into the LC-MS system. In [21], a study was made of SPE as well as 
LLE as sample pretreatment prior to CZE-MS. In SPE, urine was evaporated to dryness, 
reconstituted in methanol, centrifuged and applied to a silica gel column. The eluent was 
again evaporated to dryness and reconstituted prior to injection. In LLE, 500 μL EtOAc/
ACN (9:1) was used to extract acylcarnitines from 500 μL urine. The organic layer was 
evaporated and the residue was reconstituted in 200 μL 1.5% FA in methanol, which was 
used for injection. 
Analyte R2
value
Mean relative   
standard  
deviation (%)











acetyl 0.9962 11.3 11.8 14.7 112 52
hexanoyl 0.9978 5.6 7.3 0.083 23 84
decanoyl 0.9995 4.7 7.2 - - 96
stearoyl 0.9934 7.4 10.8 0.051 23 90
Table 5.2 validation results for cEE-LC-MS of several acylcarnitines in urine 
(*: concentrations obtained from standard addition calibration curves of Fig. 5.5)
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The recovery of cEE-LC-MS was calculated by determining the ratio of the slopes of 
the calibration curves from urine and water and expressed as percentages. The results (Table 
5.2) indicate that cEE of hexanoylcarnitine, decanoylcarnitine and stearoylcarnitine are 
affected only to a limited extent by the urine matrix, or hardly at all (decanoylcarnitine). 
The recovery of acetylcarnitine is rather low; this may be explained, as mentioned above, by 
the fact that it co-elutes in the void volume with various other compounds in LC, leading to 
less favourable electrospray conditions (ion suppression). 
In total, more than 60 peaks have been detected in cEE-LC-MS of urine with the 
internal standard octanoylcarnitine as the only spike. Of these, 17 masses could be putatively 
annotated using the accurate mass and elemental composition (determined with the 
SmartFormula function of the Bruker Daltonics DataAnalysis software) in combination with 
the Human Metabolome Database (www.hmdb.ca) and a literature search (see references 
in Table 5.3). Interestingly, apart from the three acylcarnitines already described, strong 
indications of the presence of five more endogenous acylcarnitines were found. In Fig. 5.6A, 
a reconstructed cEE-LC-MS chromatogram with only the acylcarnitines peaks is shown and 
in Fig. 5.6B, all peaks are shown. To be conclusive about the identity of the 5 acylcarnitines 

































A) only acylcarnitines B) all peaks
Figure 5.6 cEE-LC-MS chromatogram of  A) reconstructed ion chromatograms of endogenous acylcarnitines, 
except for the added spike octanoyl carnitine, in urine; acylcarnitines mentioned in bold are identified by adding 
standards, other acetyl carnitines are putative; (8:1) means the acyl group contains 8 C atoms and one double 
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order of these acylcarnitines is supporting the identification; it corresponds well with the 
expectations based on their polarity and with what has been reported previously [22].  To 
elucidate the exact structure of (iso)butyrylcarnitine, (iso)valerylcarnitine, octenoylcarnitine 
(8:1 carnitine) and decenoylcarnitine (10:1), MS/MS work should be done. In the Human 
Metabolome Database and in [24] only 9-decenoylcarnitine and 2-octenoylcarnitine are 
mentioned, indicating that these are the found acylcarnitine species.
In [22], it is stated that a typical LC-MS chromatogram (150 x 2.0 mm C8 column) of 
healthy urine shows an acetylcarnitine peak, and depending on the urine concentration, also 
propionylcarnitine and (iso-)valerylcarnitine can be observed. In [21], only acetylcarnitine 
could be quantified with CZE-MS, the other acylcarnitine being detectable but could not be 
quantified. With the cEE-LC-MS method developed, combining the electrophoretic with 
the chromatographic approach, 7 acylcarnitines peaks that were high enough for quantitation 
were found and of three of them, trace concentrations could actually be determined in only 
2 μL urine.   
3.3  EE as sample pretreatment prior to CZE
The combination of EE with LC offers selectivity, since the electrophoretic as well as 
the chromatographic mechanism is employed during analysis. For example, when EE is 
Table 5.3 Putatively identified metabolites in 2 μL urine, analyzed with cEE-LC-MS
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coupled to RP-LC, as is carried out in [10] and in this work, the system is suitable for the 
analysis of charged, rather apolar compounds, such as peptides, and acylcarnitines. The 
charge of the analytes makes them susceptible to the electric field strength that is employed 
during EE, while their apolar character ensures retention on the RP column. For a more 
comprehensive (i.e. less selective and therefore less discriminative) approach desirable in 
metabolomics analysis, the combination of EE with CZE is attractive, since both techniques 
are electromigration techniques and all compounds that are feasible in EE should be feasible 
in CZE, regardless their polarity. 
To explore the applicability of EE prior to CZE, an off-line EE experiment of urine 
spiked with acetylcarnitine, octanoylcarnitine and decanoylcarnitine (2 μM each) prior to 
EE, was carried out, after which the extract was injected into a CZE-MS system. The resulting 
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Figure 5.7 Results from off-line EE-CZE-MS. Acetylcarnitine, octanoylcarnitine and 




Large volume cEE-LC-MS of metabolites
electropherogram (Fig. 5.7) showed good separation of all endogenous acylcarnitines that 
were found using on-line cEE-LC-MS, except for hexanoylcarnitine, which was not present. 
These first results indicate that the high salt concentration in urine does not have a negative 
effect on the CZE separation, a well-known complication in CZE analysis of biological 
samples [35]. Possibly, the salt precipitates when the urine is mixed with EtOAc. Future 
experiments are directed at investigating this process. Moreover, almost twice as many peaks 
were observed as with cEE-LC-MS, as a matter of fact more than 100. The combination of 
large volume EE with CZE has great potential and the direct on-line coupling of EE to CZE 
has our current attention. 
4. Conclusions
The intention of this study was to demonstrate the great potential of EE in metabolite 
analysis. Our results indicate that electromigration-based sample pretreatment techniques 
for bio-analysis deserve more attention. We successfully demonstrated the applicability of 
EE as sample pretreatment of low-abundant urine metabolites in urine. Also, we showed 
that many compounds, belonging to several classes, can be extracted from untreated urine 
samples with EE. Using acylcarnitines as an example in on-line cEE-LC-MS, it was shown 
that EE is linear, sensitive and has a high recovery. In aliquots of only 2 μL urine, 10 
endogenous acylcarnitines could be found. Three of them were quantified with the standard 
addition method. In an off-line EE/CZE-MS experiment, the same acylcarnitines were 
found, along with around 100 other putative metabolites. This demonstrates that EE is a 
versatile technique and that combining EE with CZE, has great potential. Further work will 
be directed to the on-line coupling of large volume cEE to CZE-MS and identification of 
all extracted metabolites.
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Summary, conclusions and perspectives
The paradigm shift from reductionism towards systems thinking has stimulated the 
field of analytical chemistry to develop bio-analytical techniques that are faster, more 
comprehensive, and have lower detection limits. 
In this thesis, it is demonstrated that electrophoretic methods can be exploited to achieve 
these developments. For this, carefully chosen electrolyte systems were used, leading to 
conditions that were suitable for isotachophoresis (ITP) or electroextraction (EE). In such a 
suitable electrolyte system, an analyte flux can be generated by an electric field. This analyte 
flux can be utilised to carry out on-line preconcentration of the analytes. In addition, in 
ITP the analytes are simultaneously separated. All peptides and a large part of the known 
metabolites are charged or can become charged by varying pH; consequently, migration of 
these compounds can be manipulated by application of an electric field. 
In Chapter 2, the potential of capillary isotachophoresis (cITP) coupled to mass 
spectrometry (MS) of peptides using spacer molecules was explored as a strategy to detect 
peptides one by one. cITP-MS combines the concentrating power of cITP with the selective 
and sensitive detection power of MS. In principle, cITP-MS has great potential for the 
analysis of low-abundant peptides and metabolites, due to its ability to concentrate and 
separate analytes simultaneously. However, a major limitation has to be overcome, namely 
the mixing of ITP zones during transfer to MS: as soon as ITP conditions are abandoned, 
the concentrating effect, which is the key characteristic of ITP, is diminished and the 
isotachophoretic zones start to collapse and mix. When the isotachophoretic zones are very 
narrow, as is the case with low-abundant analytes, the collapsing of these zones results in 
zones that contain multiple peptides. Proof-of-principle experiments are described in which 
spacer compounds are added to a peptide sample prior to cITP separation. As expected, 
the peptides are physically separated by the spacer molecules and enter the MS one by one 
instead of all at once, as happened when no spacer molecules were added. 
During the study, it was noticed that the spacer compound mixture that was used 
(carrier ampholytes (CA)) needed improving. CA mixtures were originally developed to 
generate stable pH gradients in isoelectric focusing (IEF). However, the currently available 
CA mixtures have not been well defined and contain high levels of neutral contaminations 
which are present in all ITP zones, frustrating MS detection and resulting in less favourable 
detection limits or even no analyte detection at all. A solution for this could be to clean up 
the CA mixture prior to use, for example by performing weak cation exchange solid phase 
extraction. A more elegant solution would be to develop a well-defined spacer compound 
mixture dedicated to ITP use and of which the exact composition is known, including the 
119
6
Summary, conclusions and perspectives
electrophoretic mobilities of all the individual spacers. It is interesting to note that during 
the period IEF was invented, the theoretic concept of IEF was introduced first, and practical 
IEF was only possible after a chemist took the challenge of synthesizing appropriate CA [1]. 
In the case of ITP, suitable spacer compounds should possess electrophoretic mobilities in 
the range of the analytes, they should cause no ion suppression and they should be volatile in 
order not to clog the spray needle. In proteomics, transient ITP-CZE has been successfully 
used to concentrate and fractionate complex peptide samples prior to LC-MS analysis. 
Direct coupling of cITP to MS, using spacer molecules, will result in an analytical method 
which has improved detection limits, which covers a high dynamic range, is easy to set up, 
uncomplicated, not labour-intensive and cheap. 
The second electrophoretic approach that was studied in this thesis is electroextraction 
(EE) (Chapters 3-5). It was demonstrated that EE is a fast sample preconcentration technique 
that is quantitative, applicable to peptidomics and metabolomics, easy to automate, easy to 
hyphenate with LC-MS, and able to deal with large sample volumes (10-100 μL, with the 
possibility to further enlarge the volume).
With EE, sample molecules can be extracted rapidly into a small volume. Therefore, the 
amount of sample injected into an analytical separation can be increased without increasing 
the injected sample volume. Increasing the sample volume to achieve lower detection limits 
is often undesirable, since large amounts of contaminations are injected along with the 
compounds of interest. EE also offers selectivity; in one extraction either cations or anions 
are extracted and all other compounds, including neutrals, remain largely behind, since they 
only slowly passively migrate by diffusion into the acceptor phase.
To carry out EE, the charged sample molecules should be dissolved in a low-conductive 
(organic) donor phase that is immiscible with the (aqueous) acceptor phase, which has a 
high conductivity. When a high voltage is applied over such a liquid-liquid system, a very 
high electric field strength will be present in the low-conductive phase, causing the charged 
compounds that are present there to migrate very fast towards the acceptor phase. In the 
highly conductive acceptor phase, a very low electric field strength exists and the charged 
compounds are slowed down as they enter; therefore, they are concentrated just after they 
have passed the liquid-liquid interface. 
In this thesis, two on-line set-ups for EE-LC-MS were successfully demonstrated: capillary 
EE (cEE) (Chapter 3) and large volume cEE (Chapter 4 and 5). The main differences 
between cEE and large volume cEE were the positioning of the liquid phases and the volume 
of organic donor phase that could be extracted.
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In cEE (Chapter 3), the aqueous acceptor phase was positioned in a capillary and the 
organic donor phase in a sample vial, in which the grounded capillary was immersed as well 
as an electrode. When an electric field strength was applied, approximately 10 μL organic 
phase could be depleted from cationic analytes, which migrated into the aqueous phase in 
the capillary. The collected sample plug was transferred to an LC-MS system via a switching 
valve. A peptide enrichment factor of around 100 times in comparison to a conventional 
reversed phase LC injection of the organic donor phase was achieved, demonstrating the 
capacity of EE to increase the loadability of LC-MS. With this set-up, it was shown for the 
first time that EE is suitable for enrichment of biomolecules (peptides) from a biological 
matrix (urine). 
In Chapter 4 and 5 cEE-LC-MS was further improved, so that it could extract larger 
sample volumes (100 μl instead of 10 μL, e.g. large volume cEE-LC-MS) in order to 
achieve higher enrichment factors (and therefore improve detection limits). Moreover, the 
repeatability of EE was improved. These improvements were achieved by performing EE in a 
large bore capillary, in which the whole extraction volume of organic phase is injected. Then, 
extraction from this large, well-defined and controlled organic sample volume took place. 
Peptide enrichment factors were improved to approximately three orders of magnitude and 
it was demonstrated that the method is also suitable for also acylcarnitines. With on-line 
large volume cEE-LC-MS, peptides in plasma as well as low abundant metabolites in urine 
were determined. 
In this thesis, large volume cEE was used to hyphenate SPE off-line with reversed phase 
LC-MS. Normally, SPE extracts have to be evaporated to dryness and reconstituted prior 
to reversed phase LC-MS in order to be able to inject a sample amount large enough. Both 
evaporation and reconstitution are labour intensive, result in sample loss and introduce 
errors in the measurement. In this thesis, it is demonstrated that due to the implementation 
of cEE, these steps can be eliminated. The construction of a fully automated, closed analytical 
system in which SPE is coupled on-line to large volume cEE-LC-MS is foreseeable. Such a 
system minimises experimental errors, sample loss and labour, since no human interference 
is required after filling the autosampler with the appropriate samples. For full hyphenation 
of SPE to LC-MS via large volume cEE, the organic solvent should be able to elute the 
compounds of interest from the SPE material as well as to serve as a donor solvent in EE. 
In Chapter 5, the combination of large volume cEE with CZE-MS for the analysis 
of low abundant urine metabolites, using acylcarnitines as example, is demonstrated and 
shown to be promising. The on-line coupling with CZE is attractive, since large volume 
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cEE can overcome a major limitation of CZE, namely its low volume loadability. To obtain 
a reliable on-line coupling of large volume cEE to CZE, a dedicated valve could for example 
be developed. 
In all the EE work described in this thesis, only ethyl acetate (EtOAc) was used as organic 
donor solvent. EtOAc is a suitable solvent, since it can form a two-phase system with water 
and it can contain some (up to 3.5%) water to enable the presence of ions. The range of 
compounds that can be extracted (in terms of polarity, for example) can be further expanded 
by using other organic solvents or solvent mixtures.
The EE process lends itself very well to microfluidic applications. In an EE-chip, very 
small volumes can be extracted and the use of high voltage equipment is unnecessary since in 
these small dimensions high field strengths can already be achieved with low voltages. When 
on-chip EE is successfully developed, the consecutive development of small, easy-to-operate 
EE equipment coupled on-line to analytical separations is foreseeable.
To summarise, we have demonstrated in this thesis that electromigration-based sample 
pretreatment techniques for bio-analysis have great potential, showing cITP and EE 
as examples. It can be expected that such techniques will be implemented in analytical 
instrumentation in the near future. Both cITP and cEE can be expected to contribute to an 
increased coverage of the peptidome and the metabolome, which will result in the discovery 
of new biomarkers. Therefore, cITP as well as cEE have great potential to become new 
additions to the repertoire of the modern analytical chemist.
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De verschuiving van reductionisme naar systeemdenken heeft het vakgebied van de 
analytische chemie gestimuleerd om bioanalytische technieken te ontwikkelen die snel een 
breed scala aan componenten die in lage concentraties voorkomen kunnen meten. 
In dit proefschrift wordt gedemonstreerd dat elektroforetische methoden gebruikt 
kunnen worden om deze doelen te bereiken. Daartoe werden zorgvuldig gekozen 
elektrolietensystemen gebruikt, die leiden tot omstandigheden waarin isotachoforese of 
elektroextractie kan plaatsvinden. In ’een dergelijk elektrolietensysteem kan een flux van 
analieten gegenereerd worden door een elektrisch veld aan te leggen. Omdat alle peptiden 
en een groot deel van de metabolieten in geladen toestand kunnen worden gebracht door 
de pH te varieren, kunnen ze deel uit maken van deze analietenflux. Dankzij deze flux 
kunnen dus zowel peptiden als metabolieten worden geconcentreerd en, in het geval van 
isotachoforese, ook gescheiden worden. 
In Hoofdstuk 2 wordt het gebruik van zogeheten ‘spacer-moleculen’ om capillaire 
isotachoforese van peptiden aan massaspectrometrie te koppelen verkend. De koppeling 
van capillaire isotachoforese aan massaspectrometrie combineert de kracht van capillaire 
elektroforese, namelijk het concentrerende effect, met de kracht van massaspectrometrie, 
namelijk de selectieve en gevoelige detectie. In principe is deze combinatie om bovengenoemde 
redenen zeer geschikt voor de analyse van lage concentraties peptiden en metabolieten. 
Echter, de directe koppeling van isotachoforese aan massaspectrometrie is momenteel 
slechts beperkt succesvol. Dit komt omdat, zodra de experimentele omstandigheden 
die ervoor zorgen dat isotachoforese plaatsvindt verlaten worden, de scheiding en de 
concentrering die bewerkstelligd waren gedeeltelijk teniet worden gedaan. Hierdoor  raken 
de analieten deels weer met elkaar vermengd. Wanneer de analietzones zeer smal zijn, zoals 
het geval is wanneer zeer lage concentraties geanalyseerd worden, leidt dit er zelfs toe dat 
zij weer geheel vermengd raken, terwijl het concentrerende effect van isotachoforese ook 
grotendeels verloren gaat.
In dit proefschrift wordt getoond dat de toevoeging van spacer-moleculen aan het 
monster, voordat het geanalyseerd wordt, het vermengen van de analieten (in dit geval 
peptiden) tijdens het overbrengen naar de massaspectrometer kan voorkomen. Zoals 
verwacht werden de peptiden fysiek van elkaar gescheiden doordat spacer-moleculen 
zich tussen de analietzones situeerden tijdens de isotachoforetische focussering. Dit 
resulteerde in verschillende opeenvolgende massaspectra met steeds één peptide, in plaats 
van massaspectra waarin alle peptiden tegelijk voorkomen (zoals waargenomen wanneer 
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geen spacer-moleculen waren toegevoegd). Gedurende deze studie werd opgemerkt dat het 
gebruikte mengsel spacer-moleculen verbetering behoeft. Het gebruikte mengsel bestond 
uit amfolieten die normaliter worden gebruikt in experimenten waarin gewerkt wordt met 
isoëlektrisch focusseren. De exacte samenstelling van dit mengsel is onbekend en het bevat 
een hoog gehalte vervuilingen die massaspectrometrische detectie negatief beïnvloeden 
vanwege ionensuppressie. Een mogelijk oplossing voor dit probleem is het opschonen van 
het spacer-molecuulmengsel voordat het wordt toegevoegd aan het monster. Eleganter zou 
het zijn om een speciaal voor deze toepassing geschikt mengsel van spacer-moleculen te 
ontwikkelen. Deze spacer-moleculen moeten over elektroforetische mobiliteiten beschikken 
die in hetzelfde bereik liggen als de mobiliteiten van de te analyseren componenten. Daarnaast 
moeten zij geen ionensuppressie veroorzaken bij introductie in de massaspectrometer en ze 
moeten vluchtig zijn, zodat ze de naald waarmee ze worden verneveld niet verstoppen.
De directe koppeling van capillaire isotachoforese aan massaspectrometrie met gebruik 
van spacer-moleculen zal resulteren in een weinig bewerkelijke, goedkope, eenvoudig op te 
zetten analytische methode met verbeterde detectielimieten en een groot dynamisch bereik.
De tweede op elektroforese gebaseerde benadering die in dit proefschrift (Hoofdstuk 
3-5) werd bestudeerd is elektroextractie. Er werd aangetoond dat elektroextractie een 
snelle, kwantitatieve techniek is die analieten concentreert. Elektroextractie is toepasbaar op 
complexe monsters die peptiden en/of metabolieten bevatten, eenvoudig te automatiseren, 
eenvoudig te koppelen aan vloeistofchromatografie en massaspectrometrie en in staat om 
grote volumes geïnjecteerd monster te extraheren (10-100 μL, met de mogelijkheid dit 
verder te vergroten).
Door middel van elektroextractie kunnen analieten snel naar een klein volume worden 
geëxtraheerd. Hierdoor kan de hoeveelheid analiet die geïnjecteerd wordt in een analytisch 
scheidingssysteem vergroot worden zonder dat het geïnjecteerde monstervolume vergroot 
wordt. Het vergroten van het geïnjecteerde monstervolume om lagere detectielimieten 
te verkrijgen is vaak ongewenst, omdat, samen met de analieten, ook grote hoeveelheden 
vervuilingen geïnjecteerd worden.
Elektroextractie biedt ook selectiviteit omdat in hetzelfde experiment óf kationen óf 
anionen worden geëxtraheerd, terwijl neutrale componenten grotendeels achterblijven 
omdat zij slechts door middel van diffusie naar de acceptorfase migreren.
Om een elektroextractie uit te voeren moeten de analieten opgelost zijn in een (organische) 
donorfase met lage geleidbaarheid, die niet mengt met een (waterige) acceptorfase met hoge 
geleidbaarheid. Als een hoog voltage over dit vloeistof-vloeistof systeem wordt aangelegd, zal 
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er een zeer hoge veldsterkte over de donorfase en een zeer lage veldsterkte over de acceptorfase 
ontstaan. Het gevolg hiervan is dat ionen die zich in de donorfase bevinden zeer snel naar 
de acceptorfase zullen migreren. Door de lage elektrische veldsterkte in de acceptorfase zal 
de migratiesnelheid van de ionen, zodra ze deze fase intreden, zeer sterk dalen. Dit heeft tot 
gevolg dat deze ionen, zodra ze het grensvlak tussen donor- en acceptorfase gepasseerd zijn, 
sterk geconcentreerd worden. 
In dit proefschrift worden twee succesvolle on-line opstellingen gepresenteerd die 
elektroextractie koppelen aan vloeistofchromatografie en massaspectrometrie: capillaire 
elektroextractie (Hoofdstuk 3) en groot-volume capillaire elektroextractie (Hoofdstuk 4 en 
5). De belangrijkste verschillen tussen beide opstellingen liggen in de positionering van de 
vloeistoffases en het extractievolume.
In capillaire elektroextractie (Hoofdstuk 3) bevinden de waterige acceptorfase zich 
in een capillair en de organische donorfase in een monstervaatje. Het ene uiteinde van 
het capillair bevindt zich in de organische fase, het andere uiteinde is geaard. Daarnaast 
bevindt zich ook een elektrode in de organische fase. Zodra een elektrisch veld werd 
aangelegd, migreerden de ionen vanuit de organische donorfase de waterige acceptorfase 
in om daar geconcentreerd te worden. Op deze manier konden alle analieten uit ongeveer 
10 μL organische fase geëxtraheerd worden. De aldus verzamelde analietenzone werd via 
een schakelkraan geïnjecteerd in een vloeistofchromatografie-massaspectrometrie systeem. 
Directe vergelijking met een conventionele injectie in een dergelijk systeem liet zien dat 
de peptiden ongeveer 100 keer verrijkt konden worden met behulp van elektroextractie 
en dat dus de belaadbaarheid van vloeistofchromatografie met deze factor vergroot was. 
Experimenten met urinemonsters resulteerden in de constatering dat elektroextractie 
geschikt is voor de extractie van peptiden uit complexe biologische monsters.
In Hoofdstuk 4 en 5 werd het systeem verder verbeterd zodat grotere volumes organische 
donorfase geëxtraheerd konden worden. Door het extractievolume te vergroten van 10 μL 
naar 100 μL kon meer verrijking en daardoor dus betere detectielimieten bereikt worden. 
Ook kon de herhaalbaarheid van elektroextractie verbeterd worden. Deze verbeteringen 
werden bewerkstelligd door de elektroextractie te laten plaatsvinden in een capillair met grote 
diameter waarin het te extraheren volume organische fase geïnjecteerd werd. In dit capillair 
vond elektroextractie vanuit een goed gedefinieerd volume donorfase plaats, resulterend in 
verrijkingsfactoren van peptiden van rond de 1000. Met deze opstelling zijn peptiden en 
metabolietensporen in zowel bloedplasma als urine bepaald.
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Groot-volume elektroextractie kan goed worden gecombineerd worden met vaste-
stof-extractie. Gewoonlijk wordt het eluens dat de analieten bevat na vaste-stof-extractie 
gevriesdroogd en heropgelost voordat het in een vloeistofchromatografiesysteem geïnjecteerd 
kan worden. Zowel het vriesdrogen als het heroplossen zijn bewerkelijke stappen, die 
bovendien experimentele fouten in de analyse introduceren en verlies van analiet opleveren. 
In dit proefschrift wordt gedemonstreerd dat deze stappen weg gelaten kunnen worden 
door het eluens te vermengen met een geschikte donorfase zodat er direct elektroextractie 
kan worden uitgevoerd. Het valt te voorzien dat een volledig gesloten analytisch system 
ontwikkeld zal worden, waarin vaste-stof-extractie via elektroextractie gekoppeld is aan 
vloeistofchromatografie met massaspectrometrische detectie. In zo’n systeem zullen 
experimentele fouten tot een minimum beperkt zijn, evenals het verlies van analiet. Daarnaast 
zal de gebruiker na het inladen van de monsters geen bemoeienis meer hoeven te hebben 
met de analyse. Om vaste-stof-extractie direct on-line met elektroextractie te koppelen moet 
het eluens dat gebruikt wordt om de analieten van de extractiekolom te elueren ook geschikt 
zijn om te dienen als organische donorfase in elektroextractie te dienen.
In Hoofdstuk 5 wordt de combinatie van elektroextractie met capillaire zone 
elektroforese gedemonstreerd veelbelovend te zijn. De on-line koppeling van elektroextractie 
met capillaire zone elektroforese is aantrekkelijk, omdat elektroextractie een belangrijke 
beperking van capillaire zone elektroforese, namelijk de lage belaadbaarheid ervan, kan 
verhelpen. Om elektroextractie on-line te koppelen zou bijvoorbeeld een daartoe speciaal 
geschikte schakelkraan ontwikkeld kunnen worden.
Samenvattend kan gesteld worden dat we  in dit proefschrift, aan de hand van 
capillaire isotachoforese en elektroextractie, gedemonstreerd hebben dat de toepassing 
van op elektromigratie gebaseerde monstervoorbewerkingstechnieken in de bioanalyse 
grote potentie heeft. Het ligt in de lijn der verwachting dat zulke technieken in de nabije 
toekomst meer toegepast gaan worden in analytische instrumentatie. Van zowel capillaire 
isotachoforese als van elektroextractie kan verwacht worden dat zij de kennis van de in 
biologische monsters aanwezige peptiden en metabolieten zal vergroten, wat kan resulteren 
in de ontdekking van nieuwe biomarkers. Om deze redenen hebben capillaire isotachoforese 
en elektroextractie grote kans om nieuwe toevoegingen aan het repertoire van de moderne 
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